{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T11:48:50Z","timestamp":1785152930549,"version":"3.55.0"},"reference-count":300,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-05917-6","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T07:15:06Z","timestamp":1779174906000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Influence of Gut Microbiome on Alpha-Synuclein Aggregation: Implications for Parkinson\u2019s Disease Pathogenesis"],"prefix":"10.1007","volume":"63","author":[{"given":"Muskan","family":"Sain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shital","family":"Rani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suraj Pratap","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pritiman","family":"Pothal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubham","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Suttee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akhilesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavitra","family":"Ranawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurpal","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi Pratap","family":"Barnwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"key":"5917_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"W Poewe K Seppi CM Tanner GM Halliday P Brundin J Volkmann AE Schrag AE Lang 2017 Parkinson disease Nat Rev Dis Primers 3 17013https:\/\/doi.org\/10.1038\/nrdp.2017.13","journal-title":"Nat Rev Dis Primers"},{"key":"5917_CR2","doi-asserted-by":"publisher","unstructured":"A. Bharwani JB, P. Forsythe (2017) The interplay between the microbiota and the central nervous system during neurodevelopment. In: Microbiota in health and disease: from pregnancy to childhood. Wageningen Academic, pp 151\u2013162. https:\/\/doi.org\/10.3920\/978-90-8686-839-1","DOI":"10.3920\/978-90-8686-839-1"},{"issue":"2","key":"5917_CR3","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/mds.27607","volume":"34","author":"DE Mor","year":"2019","unstructured":"Mor DE, Daniels MJ, Ischiropoulos H (2019) The usual suspects, dopamine and alpha-synuclein, conspire to cause neurodegeneration. Mov Disord 34(2):167\u2013179. https:\/\/doi.org\/10.1002\/mds.27607","journal-title":"Mov Disord"},{"issue":"2","key":"5917_CR4","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/s0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"H Braak K Tredici Del U Rub RA Vos de EN Jansen Steur E Braak 2003 Staging of brain pathology related to sporadic Parkinson\u2019s disease Neurobiol Aging 24 2 197 211 https:\/\/doi.org\/10.1016\/s0197-4580(02)00065-9","journal-title":"Neurobiol Aging"},{"issue":"Suppl 2","key":"5917_CR5","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1002\/mds.27795","volume":"34","author":"Abstracts of the","year":"2019","unstructured":"Abstracts of the 2019 International Congress of the Parkinson\u2019s Disease and Movement Disorders(R) (2019) Mov Disord 34 Suppl 2 S1 S930 https:\/\/doi.org\/10.1002\/mds.27795","journal-title":"Mov Disord"},{"key":"5917_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-080952","volume":"388","author":"D Su","year":"2025","unstructured":"Su D, Cui Y, He C, Yin P, Bai R, Zhu J, Lam JST, Zhang J et al (2025) Projections for prevalence of Parkinson\u2019s disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021. BMJ 388:e080952https:\/\/doi.org\/10.1136\/bmj-2024-080952","journal-title":"BMJ"},{"issue":"s1","key":"5917_CR7","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.3233\/JPD-181474","volume":"8","author":"ER Dorsey","year":"2018","unstructured":"ER Dorsey T Sherer MS Okun BR Bloem 2018 The emerging evidence of the Parkinson pandemic J Parkinsons Dis 8 s1 S3 S8 https:\/\/doi.org\/10.3233\/JPD-181474","journal-title":"J Parkinsons Dis"},{"issue":"5999","key":"5917_CR8","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1126\/science.1195227","volume":"329","author":"J Burre","year":"2010","unstructured":"J Burre M Sharma T Tsetsenis V Buchman MR Etherton TC Sudhof 2010 Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro Science 329 5999 1663 1667 https:\/\/doi.org\/10.1126\/science.1195227","journal-title":"Science"},{"issue":"1","key":"5917_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1001\/jamaneurol.2017.3299","volume":"75","author":"ER Dorsey","year":"2018","unstructured":"ER Dorsey BR Bloem 2018 The Parkinson pandemic-a call to action JAMA Neurol 75 1 9 10 https:\/\/doi.org\/10.1001\/jamaneurol.2017.3299","journal-title":"JAMA Neurol"},{"issue":"13","key":"5917_CR10","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/mds.25945","volume":"29","author":"T Pringsheim","year":"2014","unstructured":"T Pringsheim N Jette A Frolkis TD Steeves 2014 The prevalence of Parkinson\u2019s disease: a systematic review and meta-analysis Mov Disord 29 13 1583 1590 https:\/\/doi.org\/10.1002\/mds.25945","journal-title":"Mov Disord"},{"issue":"19","key":"5917_CR11","doi-asserted-by":"publisher","first-page":"6546","DOI":"10.1080\/10408398.2023.2170972","volume":"64","author":"S Zhang","year":"2024","unstructured":"S Zhang B Mao S Cui Q Zhang J Zhao X Tang W Chen 2024 Absorption, metabolism, bioactivity, and biotransformation of epigallocatechin gallate Crit Rev Food Sci Nutr 64 19 6546 6566 https:\/\/doi.org\/10.1080\/10408398.2023.2170972","journal-title":"Crit Rev Food Sci Nutr"},{"key":"5917_CR12","doi-asserted-by":"crossref","unstructured":"Sanderman R, Morgan K (2024) In: The Routledge international handbook of health psychology global and contemporary issues, 1st edn. Routledge Taylor & Francis group","DOI":"10.4324\/9781003318026"},{"key":"5917_CR13","doi-asserted-by":"publisher","unstructured":"Kouli A, Torsney KM, Kuan W-L (2018) Parkinson\u2019s disease: etiology, neuropathology, and pathogenesis. Parkinson\u2019s Disease: Pathogenesis and Clinical Aspects:3\u201326. https:\/\/doi.org\/10.15586\/CODONPUBLICATIONS.PARKINSONSDISEASE.2018.CH1","DOI":"10.15586\/CODONPUBLICATIONS.PARKINSONSDISEASE.2018.CH1"},{"issue":"11","key":"5917_CR14","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/nrneurol.2015.197","volume":"11","author":"L Klingelhoefer","year":"2015","unstructured":"L Klingelhoefer H Reichmann 2015 Pathogenesis of Parkinson disease--the gut-brain axis and environmental factors Nat Rev Neurol 11 11 625 636 https:\/\/doi.org\/10.1038\/nrneurol.2015.197","journal-title":"Nat Rev Neurol"},{"issue":"6","key":"5917_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.11.018","volume":"167","author":"TR Sampson","year":"2016","unstructured":"Sampson TR, Debelius JW, Thron T, Janssen S, Shastri GG, Ilhan ZE, Challis C, Schretter CE, et al. (2016) Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson\u2019s Disease. Cell 167(6):e1412. https:\/\/doi.org\/10.1016\/j.cell.2016.11.018","journal-title":"Cell"},{"issue":"2","key":"5917_CR16","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.tins.2022.11.007","volume":"46","author":"M Sharma","year":"2023","unstructured":"M Sharma J Burre 2023 Alpha-Synuclein in synaptic function and dysfunction Trends Neurosci 46 2 153 166 https:\/\/doi.org\/10.1016\/j.tins.2022.11.007","journal-title":"Trends Neurosci"},{"key":"5917_CR17","doi-asserted-by":"publisher","DOI":"10.1111\/nan.12311","author":"MG Spillantini","year":"2016","unstructured":"MG Spillantini M Goedert 2016 Synucleinopathies: past, present and future Neuropathol Appl Neurobiol https:\/\/doi.org\/10.1111\/nan.12311","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"2","key":"5917_CR18","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrn.2016.178","volume":"18","author":"DJ Surmeier","year":"2017","unstructured":"DJ Surmeier JA Obeso GM Halliday 2017 Selective neuronal vulnerability in Parkinson disease Nat Rev Neurosci 18 2 101 113 https:\/\/doi.org\/10.1038\/nrn.2016.178","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"5917_CR19","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/mds.26069","volume":"30","author":"F Scheperjans","year":"2015","unstructured":"Scheperjans F, Aho V, Pereira PA, Koskinen K, Paulin L, Pekkonen E, Haapaniemi E, Kaakkola S et al (2015) Gut microbiota are related to Parkinson\u2019s disease and clinical phenotype. Mov Disord 30 (3):350-358.https:\/\/doi.org\/10.1002\/mds.26069","journal-title":"Mov Disord"},{"issue":"13","key":"5917_CR20","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.2174\/1570159X21666230907151226","volume":"22","author":"B Vincent","year":"2024","unstructured":"B Vincent M Shukla 2024 The common denominators of Parkinson\u2019s disease pathogenesis and methamphetamine abuse Curr Neuropharmacol 22 13 2113 2156 https:\/\/doi.org\/10.2174\/1570159X21666230907151226","journal-title":"Curr Neuropharmacol"},{"issue":"2","key":"5917_CR21","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S1474-4422(19)30356-4","volume":"19","author":"JF Cryan","year":"2020","unstructured":"JF Cryan KJ O\u2019Riordan K Sandhu V Peterson TG Dinan 2020 The gut microbiome in neurological disorders Lancet Neurol 19 2 179 194 https:\/\/doi.org\/10.1016\/S1474-4422(19)30356-4","journal-title":"Lancet Neurol"},{"issue":"5","key":"5917_CR22","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/mds.26942","volume":"32","author":"EM Hill-Burns","year":"2017","unstructured":"Hill-Burns EM, Debelius JW, Morton JT, Wissemann WT, Lewis MR, Wallen ZD, Peddada SD, Factor SA et al (2017) Parkinson\u2019s disease and Parkinson's disease medications have distinct signatures of the gut microbiome. Mov Disord 32 (5):739-749.https:\/\/doi.org\/10.1002\/mds.26942","journal-title":"Mov Disord"},{"key":"5917_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122357","volume":"337","author":"CL Goncalves","year":"2024","unstructured":"CL Goncalves T Doifode VL Rezende MA Costa JM Rhoads CA Soutullo 2024 The many faces of microbiota-gut-brain axis in autism spectrum disorder Life Sci 337 122357https:\/\/doi.org\/10.1016\/j.lfs.2023.122357","journal-title":"Life Sci"},{"key":"5917_CR24","doi-asserted-by":"publisher","unstructured":"Pathak YV, Pathak S, Stough C (2023) Anxiety, gut microbiome, and nutraceuticals: recent trends and clinical evidence. Anxiety, Gut Microbiome, and Nutraceuticals: Recent Trends and Clinical Evidence:1\u2013419. https:\/\/doi.org\/10.1201\/9781003333821\/ANXIETY-GUT-MICROBIOME-NUTRACEUTICALS-SARVADAMAN-PATHAK-YASHWANT-PATHAK-CON-STOUGH\/RIGHTS-AND-PERMISSIONS","DOI":"10.1201\/9781003333821\/ANXIETY-GUT-MICROBIOME-NUTRACEUTICALS-SARVADAMAN-PATHAK-YASHWANT-PATHAK-CON-STOUGH\/RIGHTS-AND-PERMISSIONS"},{"issue":"4","key":"5917_CR25","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","volume":"103","author":"S Kim","year":"2019","unstructured":"Kim S, Kwon SH, Kam TI, Panicker N, Karuppagounder SS, Lee S, Lee JH, Kim WR, et al. (2019) Transneuronal propagation of pathologic alpha-Synuclein from the gut to the brain models Parkinson\u2019s disease. Neuron 103(4):627\u2013641. https:\/\/doi.org\/10.1016\/j.neuron.2019.05.035","journal-title":"Neuron"},{"key":"5917_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.861035","volume":"14","author":"R Yang","year":"2022","unstructured":"R Yang G Gao H Yang 2022 The pathological mechanism between the intestine and brain in the early stage of Parkinson\u2019s disease Front Aging Neurosci 14 861035https:\/\/doi.org\/10.3389\/fnagi.2022.861035","journal-title":"Front Aging Neurosci"},{"key":"5917_CR27","doi-asserted-by":"publisher","DOI":"10.1159\/000026225","author":"JM Gorell","year":"1999","unstructured":"JM Gorell BA Rybicki CC Johnson EL Peterson 1999 Occupational metal exposures and the risk of Parkinson\u2019s disease Neuroepidemiology https:\/\/doi.org\/10.1159\/000026225","journal-title":"Neuroepidemiology"},{"issue":"5","key":"5917_CR28","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1212\/wnl.50.5.1346","volume":"50","author":"JM Gorell","year":"1998","unstructured":"JM Gorell CC Johnson BA Rybicki EL Peterson RJ Richardson 1998 The risk of Parkinson\u2019s disease with exposure to pesticides, farming, well water, and rural living Neurology 50 5 1346 1350 https:\/\/doi.org\/10.1212\/wnl.50.5.1346","journal-title":"Neurology"},{"key":"5917_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-018-0058-0","volume":"4","author":"C Marras","year":"2018","unstructured":"Marras C, Beck JC, Bower JH, Roberts E, Ritz B, Ross GW, Abbott RD, Savica R, et al. (2018) Prevalence of Parkinson\u2019s disease across North America. npj Park Dis 4:21. https:\/\/doi.org\/10.1038\/s41531-018-0058-0","journal-title":"npj Park Dis"},{"key":"5917_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11122467","author":"S Pyatha","year":"2022","unstructured":"S Pyatha H Kim D Lee K Kim 2022 Association between heavy metal exposure and Parkinson\u2019s disease: a review of the mechanisms related to oxidative stress Antioxidants Basel https:\/\/doi.org\/10.3390\/antiox11122467","journal-title":"Antioxidants Basel"},{"issue":"7","key":"5917_CR31","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1002\/mds.28052","volume":"35","author":"MS Cirstea","year":"2020","unstructured":"Cirstea MS, Yu AC, Golz E, Sundvick K, Kliger D, Radisavljevic N, Foulger LH, Mackenzie M et al (2020) Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease. Mov Disord 35 (7):1208-1217.https:\/\/doi.org\/10.1002\/mds.28052","journal-title":"Mov Disord"},{"key":"5917_CR32","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3389\/fnins.2019.00028","volume":"13","author":"M Huang","year":"2019","unstructured":"M Huang B Wang X Li C Fu C Wang X Kang 2019 Alpha-synuclein: a multifunctional player in exocytosis, endocytosis, and vesicle recycling Front Neurosci 13 28 https:\/\/doi.org\/10.3389\/fnins.2019.00028","journal-title":"Front Neurosci"},{"issue":"3","key":"5917_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05672-9","volume":"14","author":"P Calabresi","year":"2023","unstructured":"Calabresi P, Mechelli A, Natale G, Volpicelli-Daley L, Di Lazzaro G, Ghiglieri V (2023) Alpha-synuclein in Parkinson\u2019s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction. Cell Death Dis 14(3):176. https:\/\/doi.org\/10.1038\/s41419-023-05672-9","journal-title":"Cell Death Dis"},{"issue":"2","key":"5917_CR34","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s11011-025-01542-9","volume":"40","author":"SM Razavi","year":"2025","unstructured":"Razavi SM, Esmaealzadeh N, Ataei M, Afshari N, Saleh M, Amini Y, Hasrati S, Ghazizadeh Hashemi F et al (2025) The effects of ursodeoxycholic acid on Parkinson's disease, a mechanistic review of the recent evidence. Metab Brain Dis 40 (2):115.https:\/\/doi.org\/10.1007\/s11011-025-01542-9","journal-title":"Metab Brain Dis"},{"key":"5917_CR35","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.neuroscience.2024.11.070","volume":"565","author":"NL Wankhede","year":"2025","unstructured":"Wankhede NL, Kale MB, Kyada A, M RM, Chaudhary K, Naidu KS, Rahangdale S, Shende PV, et al. (2025) Sleep deprivation-induced shifts in gut microbiota: implications for neurological disorders. Neuroscience 565:99\u2013116. https:\/\/doi.org\/10.1016\/j.neuroscience.2024.11.070","journal-title":"Neuroscience"},{"issue":"1","key":"5917_CR36","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/s0896-6273(00)80886-7","volume":"25","author":"A Abeliovich","year":"2000","unstructured":"Abeliovich A, Schmitz Y, Farinas I, Choi-Lundberg D, Ho WH, Castillo PE, Shinsky N, Verdugo JM et al (2000) Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 25 (1):239-252.https:\/\/doi.org\/10.1016\/s0896-6273(00)80886-7","journal-title":"Neuron"},{"issue":"1","key":"5917_CR37","doi-asserted-by":"publisher","first-page":"85","DOI":"10.4161\/pri.23582","volume":"7","author":"DJ Surmeier","year":"2013","unstructured":"DJ Surmeier D Sulzer 2013 The pathology roadmap in Parkinson disease Prion 7 1 85 91 https:\/\/doi.org\/10.4161\/pri.23582","journal-title":"Prion"},{"issue":"1","key":"5917_CR38","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrn3406","volume":"14","author":"HA Lashuel","year":"2013","unstructured":"Lashuel HA, Overk CR, Oueslati A, Masliah E (2013) The many faces of alpha-synuclein: From structure and toxicity to therapeutic target. Nat Rev Neurosci 14(1):38\u201348. https:\/\/doi.org\/10.1038\/nrn3406","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"5917_CR39","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s40035-022-00318-w","volume":"11","author":"W Liu","year":"2022","unstructured":"Liu W, Lim KL, Tan EK (2022) Intestine-derived alpha-synuclein initiates and aggravates pathogenesis of Parkinson\u2019s disease in Drosophila. Transl Neurodegener 11(1):44. https:\/\/doi.org\/10.1186\/s40035-022-00318-w","journal-title":"Transl Neurodegener"},{"issue":"37","key":"5917_CR40","doi-asserted-by":"publisher","first-page":"10609","DOI":"10.3748\/wjg.v21.i37.10609","volume":"21","author":"A Mulak","year":"2015","unstructured":"A Mulak B Bonaz 2015 Brain-gut-microbiota axis in Parkinson\u2019s disease World J Gastroenterol 21 37 10609 10620 https:\/\/doi.org\/10.3748\/wjg.v21.i37.10609","journal-title":"World J Gastroenterol"},{"issue":"12","key":"5917_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028032","volume":"6","author":"CB Forsyth","year":"2011","unstructured":"Forsyth CB, Shannon KM, Kordower JH, Voigt RM, Shaikh M, Jaglin JA, Estes JD, Dodiya HB, et al. (2011) Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson\u2019s disease. PLoS One 6(12):e28032. https:\/\/doi.org\/10.1371\/journal.pone.0028032","journal-title":"PLoS One"},{"key":"5917_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103092","volume":"71","author":"B Kalyanaraman","year":"2024","unstructured":"Kalyanaraman B, Cheng G, Hardy M (2024) Gut microbiome, short-chain fatty acids, alpha-synuclein, neuroinflammation, and ROS\/RNS: Relevance to Parkinson\u2019s disease and therapeutic implications. Redox Biol 71:103092. https:\/\/doi.org\/10.1016\/j.redox.2024.103092","journal-title":"Redox Biol"},{"issue":"1","key":"5917_CR43","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/cns.13990","volume":"29","author":"Z Li","year":"2023","unstructured":"Li Z, Liang H, Hu Y, Lu L, Zheng C, Fan Y, Wu B, Zou T, et al. (2023) Gut bacterial profiles in Parkinson\u2019s disease: A systematic review. CNS Neurosci Ther 29(1):140\u2013157. https:\/\/doi.org\/10.1111\/cns.13990","journal-title":"CNS Neurosci Ther"},{"issue":"1","key":"5917_CR44","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12929-022-00839-6","volume":"29","author":"SJ Chen","year":"2022","unstructured":"SJ Chen CH Lin 2022 Gut microenvironmental changes as a potential trigger in Parkinson\u2019s disease through the gut-brain axis J Biomed Sci 29 1 54 https:\/\/doi.org\/10.1186\/s12929-022-00839-6","journal-title":"J Biomed Sci"},{"issue":"1","key":"5917_CR45","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-025-13545-8","volume":"273","author":"M Peters","year":"2025","unstructured":"Peters M, Hegelmaier T, Wegner F, Hollerhage M, Ye L, Niesmann C, Schneidereit IV, Haghikia A, et al. (2025) The role of the gut microbiome in the progression of Parkinson\u2019s disease: a systematic review of patient cohorts. J Neurol 273(1):8. https:\/\/doi.org\/10.1007\/s00415-025-13545-8","journal-title":"J Neurol"},{"issue":"1","key":"5917_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-021-00427-6","volume":"16","author":"VTE Aho","year":"2021","unstructured":"Aho VTE, Houser MC, Pereira PAB, Chang J, Rudi K, Paulin L, Hertzberg V, Auvinen P et al (2021) Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson's disease. Mol Neurodegener 16 (1):6.https:\/\/doi.org\/10.1186\/s13024-021-00427-6","journal-title":"Mol Neurodegener"},{"issue":"Pt A","key":"5917_CR47","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.expneurol.2017.10.017","volume":"299","author":"N Nouraei","year":"2018","unstructured":"Nouraei N, Mason DM, Miner KM, Carcella MA, Bhatia TN, Dumm BK, Soni D, Johnson DA et al (2018) Critical appraisal of pathology transmission in the alpha-synuclein fibril model of Lewy body disorders. Exp Neurol 299 (Pt A):172-196.https:\/\/doi.org\/10.1016\/j.expneurol.2017.10.017","journal-title":"Exp Neurol"},{"key":"5917_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2014.12.007","author":"AM Pickrell","year":"2015","unstructured":"AM Pickrell RJ Youle 2015 The roles of PINK1, Parkin, and mitochondrial fidelity in Parkinson\u2019s disease Neuron https:\/\/doi.org\/10.1016\/j.neuron.2014.12.007","journal-title":"Neuron"},{"key":"5917_CR49","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.brainres.2018.06.010","volume":"1702","author":"A Singh","year":"2019","unstructured":"A Singh L Zhi H Zhang 2019 LRRK2 and mitochondria: recent advances and current views Brain Res 1702 96 104 https:\/\/doi.org\/10.1016\/j.brainres.2018.06.010","journal-title":"Brain Res"},{"issue":"30","key":"5917_CR50","doi-asserted-by":"publisher","first-page":"6715","DOI":"10.1523\/JNEUROSCI.1594-04.2004","volume":"24","author":"DL Fortin","year":"2004","unstructured":"DL Fortin MD Troyer K Nakamura S Kubo MD Anthony RH Edwards 2004 Lipid rafts mediate the synaptic localization of alpha-synuclein J Neurosci 24 30 6715 6723 https:\/\/doi.org\/10.1523\/JNEUROSCI.1594-04.2004","journal-title":"J Neurosci"},{"key":"5917_CR51","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-150642","author":"J Burr\u00e9","year":"2015","unstructured":"J Burr\u00e9 2015 The synaptic function of \u03b1-synuclein J Parkinsons Dis https:\/\/doi.org\/10.3233\/JPD-150642","journal-title":"J Parkinsons Dis"},{"issue":"2-3","key":"5917_CR52","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s12017-017-8448-8","volume":"19","author":"V Delic","year":"2017","unstructured":"Delic V, Griffin JWD, Zivkovic S, Zhang Y, Phan TA, Gong H, Chaput D, Reynes C, et al. (2017) Individual amino acid supplementation can improve energy metabolism and decrease ROS production in neuronal cells overexpressing alpha-synuclein. Neuromolecular Med 19(2\u20133):322\u2013344. https:\/\/doi.org\/10.1007\/s12017-017-8448-8","journal-title":"Neuromolecular Med"},{"issue":"9","key":"5917_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10092278","volume":"10","author":"VV Goloborshcheva","year":"2022","unstructured":"VV Goloborshcheva VG Kucheryanu NA Voronina EV Teterina AA Ustyugov SG Morozov 2022 Synuclein proteins in MPTP-induced death of Substantia Nigra pars compacta dopaminergic neurons Biomedicines 10 9 2278https:\/\/doi.org\/10.3390\/biomedicines10092278","journal-title":"Biomedicines"},{"key":"5917_CR54","doi-asserted-by":"publisher","first-page":"651","DOI":"10.2147\/NDT.S235562","volume":"16","author":"S Hu","year":"2020","unstructured":"S Hu M Hu J Liu B Zhang Z Zhang FH Zhou L Wang J Dong 2020 Phosphorylation of Tau and alpha-Synuclein induced neurodegeneration in MPTP mouse model of Parkinson\u2019s Disease Neuropsychiatr Dis Treat 16 651 663 https:\/\/doi.org\/10.2147\/NDT.S235562","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"1","key":"5917_CR55","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41531-025-00902-7","volume":"11","author":"C Mu","year":"2025","unstructured":"C Mu K Shao M Su Y Guo Y Qiu R Sun S Sun Y Sun C Liu W Wang X Qin C Tang 2025 Lysophosphatidylcholine promoting alpha-Synuclein aggregation in Parkinson\u2019s disease: disrupting GCase glycosylation and lysosomal alpha-Synuclein degradation NPJ Parkinsons Dis 11 1 47 https:\/\/doi.org\/10.1038\/s41531-025-00902-7","journal-title":"NPJ Parkinsons Dis"},{"key":"5917_CR56","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1146\/annurev-biophys-060414-034057","volume":"44","author":"J Rizo","year":"2015","unstructured":"J Rizo J Xu 2015 The synaptic vesicle release machinery Annu Rev Biophys 44 339 367 https:\/\/doi.org\/10.1146\/annurev-biophys-060414-034057","journal-title":"Annu Rev Biophys"},{"issue":"7","key":"5917_CR57","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1038\/cdd.2009.217","volume":"17","author":"C Berry","year":"2010","unstructured":"Berry C, La Vecchia C, Nicotera P (2010) Paraquat and Parkinson\u2019s disease. Cell Death Differ 17(7):1115\u20131125. https:\/\/doi.org\/10.1038\/cdd.2009.217","journal-title":"Cell Death Differ"},{"issue":"1","key":"5917_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-019-0344-2","volume":"14","author":"DC Berwick","year":"2019","unstructured":"Berwick DC, Heaton GR, Azeggagh S, Harvey K (2019) LRRK2 biology from structure to dysfunction: research progresses, but the themes remain the same. Mol Neurodegener 14(1):49. https:\/\/doi.org\/10.1186\/s13024-019-0344-2","journal-title":"Mol Neurodegener"},{"issue":"3","key":"5917_CR59","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s11910-012-0265-8","volume":"12","author":"E Tsika","year":"2012","unstructured":"E Tsika DJ Moore 2012 Mechanisms of LRRK2-mediated neurodegeneration Curr Neurol Neurosci Rep 12 3 251 260 https:\/\/doi.org\/10.1007\/s11910-012-0265-8","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"4","key":"5917_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/biom13040612","volume":"13","author":"X Zhang","year":"2023","unstructured":"X Zhang A Kortholt 2023 LRRK2 structure-based activation mechanism and pathogenesis Biomolecules 13 4 612https:\/\/doi.org\/10.3390\/biom13040612","journal-title":"Biomolecules"},{"issue":"1","key":"5917_CR61","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1001\/archneurol.2008.555","volume":"66","author":"P Ibanez","year":"2009","unstructured":"Ibanez P, Lesage S, Janin S, Lohmann E, Durif F, Destee A, Bonnet AM, Brefel-Courbon C, et al. (2009) Alpha-synuclein gene rearrangements in dominantly inherited parkinsonism: frequency, phenotype, and mechanisms. Arch Neurol 66(1):102\u2013108. https:\/\/doi.org\/10.1001\/archneurol.2008.555","journal-title":"Arch Neurol"},{"issue":"1","key":"5917_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s42269-023-01047-4","volume":"47","author":"A Sayyaed","year":"2023","unstructured":"A Sayyaed N Saraswat N Vyawahare A Kulkarni 2023 A detailed review of pathophysiology, epidemiology, cellular and molecular pathways involved in the development and prognosis of Parkinson\u2019s disease with insights into screening models Bull Natl Res Cent 47 1 1 16 https:\/\/doi.org\/10.1186\/s42269-023-01047-4","journal-title":"Bull Natl Res Cent"},{"key":"5917_CR63","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ijbiomac.2013.03.057","volume":"58","author":"A Chaari","year":"2013","unstructured":"A Chaari H Horchani F Frikha R Verger Y Gargouri M Ladjimi 2013 Surface behavior of alpha-Synuclein and its interaction with phospholipids using the Langmuir monolayer technique: a comparison between monomeric and fibrillar alpha-Synuclein Int J Biol Macromol 58 190 198 https:\/\/doi.org\/10.1016\/j.ijbiomac.2013.03.057","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"5917_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-020-00367-7","volume":"15","author":"P Ge","year":"2020","unstructured":"P Ge VL Dawson TM Dawson 2020 PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson\u2019s disease Mol Neurodegener 15 1 20https:\/\/doi.org\/10.1186\/s13024-020-00367-7","journal-title":"Mol Neurodegener"},{"key":"5917_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2013.00038","volume":"4","author":"JF Trempe","year":"2013","unstructured":"Trempe JF, Fon EA (2013) Structure and function of Parkin, PINK1, and DJ-1, the Three Musketeers of neuroprotection. Front Neurol 4:38. https:\/\/doi.org\/10.3389\/fneur.2013.00038","journal-title":"Front Neurol"},{"issue":"6","key":"5917_CR66","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s10863-009-9253-3","volume":"41","author":"AJ Whitworth","year":"2009","unstructured":"AJ Whitworth LJ Pallanck 2009 The PINK1\/Parkin pathway: a mitochondrial quality control system? J Bioenerg Biomembr 41 6 499 503 https:\/\/doi.org\/10.1007\/s10863-009-9253-3","journal-title":"J Bioenerg Biomembr"},{"issue":"2","key":"5917_CR67","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1051\/medsci\/2008242118","volume":"24","author":"A Berthier","year":"2008","unstructured":"A Berthier 2008 A little bit of PINK in Parkinson\u2019s disease Med Sci (Paris) 24 2 118 119 https:\/\/doi.org\/10.1051\/medsci\/2008242118","journal-title":"Med Sci (Paris)"},{"issue":"1","key":"5917_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0006-2952(75)90304-4","volume":"24","author":"C Sachs","year":"1975","unstructured":"C Sachs G Jonsson 1975 Mechanisms of action of 6-hydroxydopamine Biochem Pharmacol 24 1 1 8 https:\/\/doi.org\/10.1016\/0006-2952(75)90304-4","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"5917_CR69","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00702-019-02133-6","volume":"127","author":"D Vareslija","year":"2020","unstructured":"D Vareslija KF Tipton GP Davey AG McDonald 2020 6-Hydroxydopamine: a far from simple neurotoxin J Neural Transm (Vienna) 127 2 213 230 https:\/\/doi.org\/10.1007\/s00702-019-02133-6","journal-title":"J Neural Transm (Vienna)"},{"key":"5917_CR70","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/978-1-4614-5836-4_170","volume":"1","author":"L Pasquali","year":"2014","unstructured":"L Pasquali E Caldarazzo-Ienco F Fornai 2014 MPTP neurotoxicity: actions, mechanisms, and animal modeling of Parkinson\u2019s disease Handb Neurotox 1 237 275 https:\/\/doi.org\/10.1007\/978-1-4614-5836-4_170","journal-title":"Handb Neurotox"},{"key":"5917_CR71","first-page":"75","volume":"3","author":"AO A","year":"2011","unstructured":"A AO, A AT (2011) Paraquat toxicity and its mode of action in some commonly consumed vegetables in Abeokuta, Nigeria. Int J Plant Physiol Biochem 3:75\u201382","journal-title":"Int J Plant Physiol Biochem"},{"issue":"4","key":"5917_CR72","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1007\/s41207-024-00537-9","volume":"9","author":"HM Flafel","year":"2024","unstructured":"HM Flafel M Rafatullah J Lalung S Al-Sodies MA Alshubramy MA Hussein 2024 Unveiling the hazards: comprehensive assessment of paraquat herbicide\u2019s toxicity and health effects Euro-Mediterr J Environ Integr 9 4 1851 1871 https:\/\/doi.org\/10.1007\/s41207-024-00537-9","journal-title":"Euro-Mediterr J Environ Integr"},{"issue":"Suppl 4","key":"5917_CR73","doi-asserted-by":"publisher","first-page":"S263","DOI":"10.5005\/jp-journals-10071-23306","volume":"23","author":"CA Sukumar","year":"2019","unstructured":"CA Sukumar V Shanbhag AB Shastry 2019 Paraquat: the poison potion Indian J Crit Care Med 23 Suppl 4 S263 S266 https:\/\/doi.org\/10.5005\/jp-journals-10071-23306","journal-title":"Indian J Crit Care Med"},{"issue":"55","key":"5917_CR74","doi-asserted-by":"publisher","DOI":"10.1002\/chem.202301721","volume":"29","author":"L Kubens","year":"2023","unstructured":"L Kubens KN Truong CW Lehmann D Lutzenkirchen-Hecht J Bornhorst F Mohr 2023 The structure of Maneb, an important Manganese-containing bis(dithiocarbamate) fungicide Chemistry 29 55 e202301721https:\/\/doi.org\/10.1002\/chem.202301721","journal-title":"Chemistry"},{"issue":"1","key":"5917_CR75","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40360-024-00755-5","volume":"25","author":"X Chang","year":"2024","unstructured":"X Chang Z Li M Tian Z Deng L Zhu G Li 2024 Rotenone activates the LKB1-AMPK-ULK1 signaling pathway to induce autophagy and apoptosis in rat thoracic aortic endothelial cells BMC Pharmacol Toxicol 25 1 33 https:\/\/doi.org\/10.1186\/s40360-024-00755-5","journal-title":"BMC Pharmacol Toxicol"},{"key":"5917_CR76","doi-asserted-by":"publisher","unstructured":"Ferrati M, Maggi F, Spinozzi E (2023) Rotenone: advances on resources, biosynthetic pathway, bioavailability, bioactivity, and pharmacology. Handbook of Dietary Flavonoids:1\u201332. https:\/\/doi.org\/10.1007\/978-3-030-94753-8_92-1","DOI":"10.1007\/978-3-030-94753-8_92-1"},{"key":"5917_CR77","volume-title":"Rotenone-a Review of its Toxicity and Use for Fisheries Management Science For Conservation 211","author":"N Ling","year":"2003","unstructured":"Ling N (2003) Rotenone-a Review of its Toxicity and Use for Fisheries Management Science For Conservation 211, 211th edn. Wellington, New Zealand","edition":"211"},{"issue":"43","key":"5917_CR78","doi-asserted-by":"publisher","first-page":"17797","DOI":"10.1073\/pnas.1113260108","volume":"108","author":"W Wang","year":"2011","unstructured":"Wang W, Perovic I, Chittuluru J, Kaganovich A, Nguyen LT, Liao J, Auclair JR, Johnson D et al (2011) A soluble alpha-synuclein construct forms a dynamic tetramer. Proc Natl Acad Sci USA 108(43):17797-17802.https:\/\/doi.org\/10.1073\/pnas.1113260108","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"5917_CR79","first-page":"879","volume":"152","author":"M Baba","year":"1998","unstructured":"M Baba S Nakajo PH Tu T Tomita K Nakaya VM Lee JQ Trojanowski T Iwatsubo 1998 Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson\u2019s disease and dementia with Lewy bodies Am J Pathol 152 4 879 884","journal-title":"Am J Pathol"},{"issue":"12","key":"5917_CR80","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/S1474-4422(24)00396-X","volume":"23","author":"F Krismer","year":"2024","unstructured":"F Krismer A Fanciulli WG Meissner EA Coon GK Wenning 2024 Multiple system atrophy: advances in pathophysiology, diagnosis, and treatment Lancet Neurol 23 12 1252 1266 https:\/\/doi.org\/10.1016\/S1474-4422(24)00396-X","journal-title":"Lancet Neurol"},{"issue":"14","key":"5917_CR81","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1056\/NEJMc1501657","volume":"372","author":"A Fanciulli","year":"2015","unstructured":"A Fanciulli GK Wenning 2015 Multiple-system atrophy N Engl J Med 372 14 1375 1376 https:\/\/doi.org\/10.1056\/NEJMc1501657","journal-title":"N Engl J Med"},{"issue":"11","key":"5917_CR82","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","volume":"95","author":"MG Spillantini","year":"1998","unstructured":"Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M (1998) Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson\u2019s disease and dementia with Lewy bodies. Proc Natl Acad Sci U S A 95(11):6469\u20136473. https:\/\/doi.org\/10.1073\/pnas.95.11.6469","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5646","key":"5917_CR83","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1090278","volume":"302","author":"AB Singleton","year":"2003","unstructured":"Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, Hulihan M, Peuralinna T, et al. (2003) Alpha-synuclein locus triplication causes Parkinson\u2019s disease. Science 302(5646):841. https:\/\/doi.org\/10.1126\/science.1090278","journal-title":"Science"},{"issue":"5","key":"5917_CR84","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/s0361-9230(01)00622-0","volume":"56","author":"DL Murphy","year":"2001","unstructured":"DL Murphy Q Li S Engel C Wichems A Andrews KP Lesch G Uhl 2001 Genetic perspectives on the serotonin transporter Brain Res Bull 56 5 487 494 https:\/\/doi.org\/10.1016\/s0361-9230(01)00622-0","journal-title":"Brain Res Bull"},{"issue":"2","key":"5917_CR85","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/mds.26479","volume":"31","author":"L Calo","year":"2016","unstructured":"Calo L, Wegrzynowicz M, Santivanez-Perez J, Spillantini GM (2016) Synaptic failure and alpha-synuclein. Mov Disord 31(2):169\u2013177. https:\/\/doi.org\/10.1002\/mds.26479","journal-title":"Mov Disord"},{"key":"5917_CR86","doi-asserted-by":"publisher","unstructured":"Paulekas E, Vanagas T, Lagunavicius S, Pajediene E, Petrikonis K, Rastenyte D (2024) Navigating the neurobiology of Parkinson\u2019s: the impact and potential of alpha-synuclein. Biomedicines 12 (9). https:\/\/doi.org\/10.3390\/biomedicines12092121","DOI":"10.3390\/biomedicines12092121"},{"key":"5917_CR87","doi-asserted-by":"publisher","unstructured":"Protein Misfolding, Aggregation, and Conformational Diseases (2006) Protein Misfolding, Aggregation, and Conformational Diseases. https:\/\/doi.org\/10.1007\/B136464","DOI":"10.1007\/B136464"},{"issue":"11","key":"5917_CR88","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/3311","volume":"4","author":"KA Conway","year":"1998","unstructured":"KA Conway JD Harper PT Lansbury 1998 Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease Nat Med 4 11 1318 1320 https:\/\/doi.org\/10.1038\/3311","journal-title":"Nat Med"},{"issue":"2","key":"5917_CR89","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a009399","volume":"2","author":"L Stefanis","year":"2012","unstructured":"Stefanis L (2012) Alpha-synuclein in Parkinson\u2019s disease. Cold Spring Harb Perspect Med 2(2):a009399. https:\/\/doi.org\/10.1101\/cshperspect.a009399","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"9440","key":"5917_CR90","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","volume":"364","author":"MC Chartier-Harlin","year":"2004","unstructured":"Chartier-Harlin MC, Kachergus J, Roumier C, Mouroux V, Douay X, Lincoln S, Levecque C, Larvor L et al (2004) Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. Lancet 364 (9440):1167-1169.https:\/\/doi.org\/10.1016\/S0140-6736(04)17103-1","journal-title":"Lancet"},{"issue":"12","key":"5917_CR91","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1038\/ng.485","volume":"41","author":"W Satake","year":"2009","unstructured":"Satake W, Nakabayashi Y, Mizuta I, Hirota Y, Ito C, Kubo M, Kawaguchi T, Tsunoda T et al. (2009) Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat Genet 41 (12):1303-1307.https:\/\/doi.org\/10.1038\/ng.485","journal-title":"Nat Genet"},{"issue":"8","key":"5917_CR92","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s00702-019-02028-6","volume":"126","author":"KA Jellinger","year":"2019","unstructured":"Jellinger KA (2019) Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update-I. hypokinetic-rigid movement disorders. J Neural Transm 126(8):933\u2013995. https:\/\/doi.org\/10.1007\/s00702-019-02028-6","journal-title":"J Neural Transm"},{"issue":"7","key":"5917_CR93","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1111\/ejn.12494","volume":"39","author":"MP Lussier","year":"2014","unstructured":"MP Lussier X Gu W Lu KW Roche 2014 Casein kinase 2 phosphorylates GluA1 and regulates its surface expression Eur J Neurosci 39 7 1148 1158 https:\/\/doi.org\/10.1111\/ejn.12494","journal-title":"Eur J Neurosci"},{"issue":"2","key":"5917_CR94","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/ncb748","volume":"4","author":"H Fujiwara","year":"2002","unstructured":"Fujiwara H, Hasegawa M, Dohmae N, Kawashima A, Masliah E, Goldberg MS, Shen J, Takio K et al (2002) alpha-Synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol 4(2):160-164.https:\/\/doi.org\/10.1038\/ncb748","journal-title":"Nat Cell Biol"},{"issue":"1","key":"5917_CR95","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1074\/jbc.275.1.390","volume":"275","author":"M Okochi","year":"2000","unstructured":"Okochi M, Walter J, Koyama A, Nakajo S, Baba M, Iwatsubo T, Meijer L, Kahle PJ et al (2000) Constitutive phosphorylation of the Parkinson's disease associated alpha-synuclein. J Biol Chem 275 (1):390-397. https:\/\/doi.org\/10.1074\/jbc.275.1.390","journal-title":"J Biol Chem"},{"issue":"21","key":"5917_CR96","doi-asserted-by":"publisher","first-page":"19213","DOI":"10.1074\/jbc.M110551200","volume":"277","author":"H Miake","year":"2002","unstructured":"H Miake H Mizusawa T Iwatsubo M Hasegawa 2002 Biochemical characterization of the core structure of alpha-synuclein filaments J Biol Chem 277 21 19213 19219 https:\/\/doi.org\/10.1074\/jbc.M110551200","journal-title":"J Biol Chem"},{"issue":"45","key":"5917_CR97","doi-asserted-by":"publisher","first-page":"44405","DOI":"10.1074\/jbc.M308041200","volume":"278","author":"GK Tofaris","year":"2003","unstructured":"GK Tofaris A Razzaq B Ghetti KS Lilley MG Spillantini 2003 Ubiquitination of alpha-synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function J Biol Chem 278 45 44405 44411 https:\/\/doi.org\/10.1074\/jbc.M308041200","journal-title":"J Biol Chem"},{"issue":"15","key":"5917_CR98","doi-asserted-by":"publisher","first-page":"9919","DOI":"10.1074\/jbc.M510127200","volume":"281","author":"V Dorval","year":"2006","unstructured":"V Dorval PE Fraser 2006 Small ubiquitin-like modifier (SUMO) modification of natively unfolded proteins tau and alpha-synuclein J Biol Chem 281 15 9919 9924 https:\/\/doi.org\/10.1074\/jbc.M510127200","journal-title":"J Biol Chem"},{"issue":"5493","key":"5917_CR99","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1126\/science.290.5493.985","volume":"290","author":"BI Giasson","year":"2000","unstructured":"Giasson BI, Duda JE, Murray IV, Chen Q, Souza JM, Hurtig HI, Ischiropoulos H, Trojanowski JQ et al (2000) Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science 290 (5493):985-989.https:\/\/doi.org\/10.1126\/science.290.5493.985","journal-title":"Science"},{"issue":"17","key":"5917_CR100","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1021\/acs.biochem.2c00104","volume":"61","author":"R Bell","year":"2022","unstructured":"Bell R, Thrush RJ, Castellana-Cruz M, Oeller M, Staats R, Nene A, Flagmeier P, Xu CK et al (2022) N-Terminal Acetylation of alpha-Synuclein Slows down Its Aggregation Process and Alters the Morphology of the Resulting Aggregates. Biochemistry 61 (17):1743-1756.https:\/\/doi.org\/10.1021\/acs.biochem.2c00104","journal-title":"Biochemistry"},{"issue":"4","key":"5917_CR101","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3233\/JPD-150642","volume":"5","author":"J Burre","year":"2015","unstructured":"Burre J (2015) The synaptic function of alpha-synuclein. J Parkinsons Dis 5(4):699\u2013713. https:\/\/doi.org\/10.3233\/JPD-150642","journal-title":"J Parkinsons Dis"},{"issue":"13","key":"5917_CR102","doi-asserted-by":"publisher","first-page":"5221","DOI":"10.1523\/JNEUROSCI.4650-14.2015","volume":"35","author":"J Burre","year":"2015","unstructured":"J Burre M Sharma TC Sudhof 2015 Definition of a molecular pathway mediating alpha-synuclein neurotoxicity J Neurosci 35 13 5221 5232 https:\/\/doi.org\/10.1523\/JNEUROSCI.4650-14.2015","journal-title":"J Neurosci"},{"issue":"4","key":"5917_CR103","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/j.ymthe.2022.01.021","volume":"30","author":"G Faustini","year":"2022","unstructured":"Faustini G, Longhena F, Masato A, Bassareo V, Frau R, Klingstedt T, Shirani H, Brembati V et al (2022) Synapsin III gene silencing redeems alpha-synuclein transgenic mice from Parkinson's disease-like phenotype. Mol Ther 30 (4):1465-1483.https:\/\/doi.org\/10.1016\/j.ymthe.2022.01.021","journal-title":"Mol Ther"},{"issue":"31","key":"5917_CR104","doi-asserted-by":"publisher","first-page":"9596","DOI":"10.1073\/pnas.1505953112","volume":"112","author":"U Dettmer","year":"2015","unstructured":"U Dettmer AJ Newman VE Saucken von T Bartels D Selkoe 2015 KTKEGV repeat motifs are key mediators of normal alpha-synuclein tetramerization: their mutation causes excess monomers and neurotoxicity Proc Natl Acad Sci U S A 112 31 9596 9601 https:\/\/doi.org\/10.1073\/pnas.1505953112","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5917_CR105","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3389\/fnins.2018.00080","volume":"12","author":"JC Bridi","year":"2018","unstructured":"JC Bridi F Hirth 2018 Mechanisms of alpha-synuclein induced synaptopathy in Parkinson\u2019s disease Front Neurosci 12 80 https:\/\/doi.org\/10.3389\/fnins.2018.00080","journal-title":"Front Neurosci"},{"issue":"1","key":"5917_CR106","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrn1583","volume":"6","author":"SO Rizzoli","year":"2005","unstructured":"SO Rizzoli WJ Betz 2005 Synaptic vesicle pools Nat Rev Neurosci 6 1 57 69 https:\/\/doi.org\/10.1038\/nrn1583","journal-title":"Nat Rev Neurosci"},{"key":"5917_CR107","doi-asserted-by":"publisher","DOI":"10.3389\/fnsyn.2010.00144","volume":"2","author":"E Neher","year":"2010","unstructured":"Neher E (2010) What is rate-limiting during sustained synaptic activity: vesicle supply or the availability of release sites. Front Synaptic Neurosci 2:144. https:\/\/doi.org\/10.3389\/fnsyn.2010.00144","journal-title":"Front Synaptic Neurosci"},{"key":"5917_CR108","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3389\/fnsyn.2010.00135","volume":"2","author":"A Denker","year":"2010","unstructured":"A Denker SO Rizzoli 2010 Synaptic vesicle pools: an update Front Synaptic Neurosci 2 135 https:\/\/doi.org\/10.3389\/fnsyn.2010.00135","journal-title":"Front Synaptic Neurosci"},{"issue":"6","key":"5917_CR109","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/9149","volume":"2","author":"VN Murthy","year":"1999","unstructured":"VN Murthy CF Stevens 1999 Reversal of synaptic vesicle docking at central synapses Nat Neurosci 2 6 503 507 https:\/\/doi.org\/10.1038\/9149","journal-title":"Nat Neurosci"},{"issue":"6","key":"5917_CR110","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.neuron.2007.09.001","volume":"55","author":"RH Edwards","year":"2007","unstructured":"RH Edwards 2007 The neurotransmitter cycle and quantal size Neuron 55 6 835 858 https:\/\/doi.org\/10.1016\/j.neuron.2007.09.001","journal-title":"Neuron"},{"key":"5917_CR111","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.22.11869","author":"D Sulzer","year":"2000","unstructured":"Sulzer D, Bogulavsky J, Larsen KE, Behr G, Karatekin E, Kleinman MH, Turro N, Krantz D, et al. (2000) Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles. Proc Natl Acad Sci U S A. https:\/\/doi.org\/10.1073\/pnas.97.22.11869","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"5917_CR112","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1080\/01616412.2024.2325312","volume":"46","author":"R El-Habta","year":"2024","unstructured":"R El-Habta S Bjerken Af A Virel 2024 N -acetylcysteine increases dopamine release and prevents the deleterious effects of 6-OHDA on the expression of VMAT2, \u03b1-synuclein, and tyrosine hydroxylase Neurol Res 46 5 406 415 https:\/\/doi.org\/10.1080\/01616412.2024.2325312","journal-title":"Neurol Res"},{"issue":"41","key":"5917_CR113","doi-asserted-by":"publisher","first-page":"38884","DOI":"10.1074\/jbc.M205518200","volume":"277","author":"J Lotharius","year":"2002","unstructured":"J Lotharius S Barg P Wiekop C Lundberg HK Raymon P Brundin 2002 Effect of mutant alpha-synuclein on dopamine homeostasis in a new human mesencephalic cell line J Biol Chem 277 41 38884 38894 https:\/\/doi.org\/10.1074\/jbc.M205518200","journal-title":"J Biol Chem"},{"issue":"7453","key":"5917_CR114","doi-asserted-by":"publisher","first-page":"E4","DOI":"10.1038\/nature12125","volume":"498","author":"J Burre","year":"2013","unstructured":"Burre J, Vivona S, Diao J, Sharma M, Brunger AT, Sudhof TC (2013) Properties of native brain alpha-synuclein. Nature 498(7453):E4-6. https:\/\/doi.org\/10.1038\/nature12125","journal-title":"Nature"},{"issue":"7419","key":"5917_CR115","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nature11320","volume":"490","author":"R Jahn","year":"2012","unstructured":"R Jahn D Fasshauer 2012 Molecular machines governing exocytosis of synaptic vesicles Nature 490 7419 201 207 https:\/\/doi.org\/10.1038\/nature11320","journal-title":"Nature"},{"key":"5917_CR116","doi-asserted-by":"publisher","unstructured":"Nordengen K, Morland C (2024) From synaptic physiology to synaptic pathology: the enigma of alpha-synuclein. Int J Mol Sci 25 (2). https:\/\/doi.org\/10.3390\/ijms25020986","DOI":"10.3390\/ijms25020986"},{"issue":"1","key":"5917_CR117","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1212\/WNL.0b013e3181e620ae","volume":"75","author":"L Brun","year":"2010","unstructured":"Brun L, Ngu LH, Keng WT, Ch'ng GS, Choy YS, Hwu WL, Lee WT, Willemsen MA et al (2010) Clinical and biochemical features of aromatic L-amino acid decarboxylase deficiency. Neurology 75 (1):64-71. https:\/\/doi.org\/10.1212\/WNL.0b013e3181e620ae","journal-title":"Neurology"},{"key":"5917_CR118","first-page":"15","volume":"30","author":"T Nagatsu","year":"1995","unstructured":"T Nagatsu 1995 Tyrosine hydroxylase: human isoforms, structure and regulation in physiology and pathology Essays Biochem 30 15 35","journal-title":"Essays Biochem"},{"key":"5917_CR119","doi-asserted-by":"publisher","unstructured":"Hoffmann GF, Assmann BE (2014) Aromatic L-amino acid decarboxylase deficiency. Congenit Neurotransmitter Dis: A Clin Approach:65\u201379. https:\/\/doi.org\/10.1212\/WNL.62.7.1058\/ASSET\/BE2B4C9C-C324-4706-88F8-ABA403D48E32\/ASSETS\/GRAPHIC\/9FF1.JPEG","DOI":"10.1212\/WNL.62.7.1058\/ASSET\/BE2B4C9C-C324-4706-88F8-ABA403D48E32\/ASSETS\/GRAPHIC\/9FF1.JPEG"},{"issue":"1","key":"5917_CR120","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.abb.2010.12.017","volume":"508","author":"SC Daubner","year":"2011","unstructured":"SC Daubner T Le S Wang 2011 Tyrosine hydroxylase and regulation of dopamine synthesis Arch Biochem Biophys 508 1 1 12 https:\/\/doi.org\/10.1016\/j.abb.2010.12.017","journal-title":"Arch Biochem Biophys"},{"issue":"5","key":"5917_CR121","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1111\/j.1471-4159.2004.02797.x","volume":"91","author":"PR Dunkley","year":"2004","unstructured":"PR Dunkley L Bobrovskaya ME Graham EI Nagy-Felsobuki von PW Dickson 2004 Tyrosine hydroxylase phosphorylation: regulation and consequences J Neurochem 91 5 1025 1043 https:\/\/doi.org\/10.1111\/j.1471-4159.2004.02797.x","journal-title":"J Neurochem"},{"issue":"8","key":"5917_CR122","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.1523\/JNEUROSCI.22-08-03090.2002","volume":"22","author":"RG Perez","year":"2002","unstructured":"RG Perez JC Waymire E Lin JJ Liu F Guo MJ Zigmond 2002 A role for alpha-synuclein in the regulation of dopamine biosynthesis J Neurosci 22 8 3090 3099 https:\/\/doi.org\/10.1523\/JNEUROSCI.22-08-03090.2002","journal-title":"J Neurosci"},{"issue":"26","key":"5917_CR123","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1093\/hmg\/10.26.3101","volume":"10","author":"O Chiba-Falek","year":"2001","unstructured":"O Chiba-Falek RL Nussbaum 2001 Effect of allelic variation at the NACP-Rep1 repeat upstream of the alpha-synuclein gene (SNCA) on transcription in a cell culture luciferase reporter system Hum Mol Genet 10 26 3101 3109 https:\/\/doi.org\/10.1093\/hmg\/10.26.3101","journal-title":"Hum Mol Genet"},{"issue":"5","key":"5917_CR124","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/0959-4388(92)90023-e","volume":"2","author":"RH Edwards","year":"1992","unstructured":"RH Edwards 1992 The transport of neurotransmitters into synaptic vesicles Curr Opin Neurobiol 2 5 586 594 https:\/\/doi.org\/10.1016\/0959-4388(92)90023-e","journal-title":"Curr Opin Neurobiol"},{"issue":"1","key":"5917_CR125","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrn1008","volume":"4","author":"GE Torres","year":"2003","unstructured":"GE Torres RR Gainetdinov MG Caron 2003 Plasma membrane monoamine transporters: structure, regulation and function Nat Rev Neurosci 4 1 13 25 https:\/\/doi.org\/10.1038\/nrn1008","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"5917_CR126","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1600-0854.2005.00259.x","volume":"6","author":"T Sorkina","year":"2005","unstructured":"T Sorkina BR Hoover NR Zahniser A Sorkin 2005 Constitutive and protein kinase C-induced internalization of the dopamine transporter is mediated by a clathrin-dependent mechanism Traffic 6 2 157 170 https:\/\/doi.org\/10.1111\/j.1600-0854.2005.00259.x","journal-title":"Traffic"},{"issue":"3","key":"5917_CR127","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/s0304-3940(03)00097-1","volume":"340","author":"C Wersinger","year":"2003","unstructured":"C Wersinger A Sidhu 2003 Attenuation of dopamine transporter activity by alpha-synuclein Neurosci Lett 340 3 189 192 https:\/\/doi.org\/10.1016\/s0304-3940(03)00097-1","journal-title":"Neurosci Lett"},{"issue":"7","key":"5917_CR128","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s00702-019-02025-9","volume":"126","author":"P Riederer","year":"2019","unstructured":"Riederer P, Berg D, Casadei N, Cheng F, Classen J, Dresel C, Jost W, Kruger R et al (2019) alpha-Synuclein in Parkinson's disease: causal or bystander? J Neural Transm (Vienna) 126 (7):815-840. https:\/\/doi.org\/10.1007\/s00702-019-02025-9","journal-title":"J Neural Transm (Vienna)"},{"issue":"5545","key":"5917_CR129","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1126\/science.1063522","volume":"294","author":"KA Conway","year":"2001","unstructured":"Conway KA, Rochet JC, Bieganski RM, Lansbury PT Jr. (2001) Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct. Science 294(5545):1346\u20131349. https:\/\/doi.org\/10.1126\/science.1063522","journal-title":"Science"},{"key":"5917_CR130","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4614-5836-4\/COVER","volume":"1\u20133","author":"RM Kostrzewa","year":"2014","unstructured":"RM Kostrzewa 2014 Handbook of neurotoxicity Handbook of Neurotoxicity 1\u20133 1 2371 https:\/\/doi.org\/10.1007\/978-1-4614-5836-4\/COVER","journal-title":"Handbook of neurotoxicity Handbook of Neurotoxicity"},{"issue":"11","key":"5917_CR131","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.1111\/j.1460-9568.2006.05181.x","volume":"24","author":"C Wersinger","year":"2006","unstructured":"C Wersinger A Jeannotte A Sidhu 2006 Attenuation of the norepinephrine transporter activity and trafficking via interactions with alpha-synuclein Eur J Neurosci 24 11 3141 3152 https:\/\/doi.org\/10.1111\/j.1460-9568.2006.05181.x","journal-title":"Eur J Neurosci"},{"issue":"2","key":"5917_CR132","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1152\/physrev.00042.2006","volume":"89","author":"R Kvetnansky","year":"2009","unstructured":"Kvetnansky R, Sabban EL, Palkovits M (2009) Catecholaminergic systems in stress: structural and molecular genetic approaches. Physiol Rev 89(2):535\u2013606. https:\/\/doi.org\/10.1152\/physrev.00042.2006","journal-title":"Physiol Rev"},{"issue":"2","key":"5917_CR133","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/mds.26421","volume":"31","author":"H McCann","year":"2016","unstructured":"H McCann H Cartwright GM Halliday 2016 Neuropathology of alpha-synuclein propagation and Braak hypothesis Mov Disord 31 2 152 160 https:\/\/doi.org\/10.1002\/mds.26421","journal-title":"Mov Disord"},{"key":"5917_CR134","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00626","volume":"12","author":"LM Butkovich","year":"2018","unstructured":"LM Butkovich MC Houser MG Tansey 2018 Alpha-synuclein and noradrenergic modulation of immune cells in Parkinson\u2019s disease pathogenesis Front Neurosci 12 626https:\/\/doi.org\/10.3389\/fnins.2018.00626","journal-title":"Front Neurosci"},{"issue":"4","key":"5917_CR135","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.jchemneu.2003.10.002","volume":"26","author":"JP Hornung","year":"2003","unstructured":"JP Hornung 2003 The human raphe nuclei and the serotonergic system J Chem Neuroanat 26 4 331 343 https:\/\/doi.org\/10.1016\/j.jchemneu.2003.10.002","journal-title":"J Chem Neuroanat"},{"issue":"6","key":"5917_CR136","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.neuropharm.2008.08.034","volume":"55","author":"DL Murphy","year":"2008","unstructured":"urphy DL, Fox MA, Timpano KR, Moya PR, Ren-Patterson R, Andrews AM, Holmes A, Lesch KP et al (2008) How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems. Neuropharmacology 55 (6):932-960.https:\/\/doi.org\/10.1016\/j.neuropharm.2008.08.034","journal-title":"Neuropharmacology"},{"issue":"2","key":"5917_CR137","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nrn2284","volume":"9","author":"DL Murphy","year":"2008","unstructured":"DL Murphy KP Lesch 2008 Targeting the murine serotonin transporter: insights into human neurobiology Nat Rev Neurosci 9 2 85 96 https:\/\/doi.org\/10.1038\/nrn2284","journal-title":"Nat Rev Neurosci"},{"issue":"6","key":"5917_CR138","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.neuron.2013.09.004","volume":"79","author":"JT Bendor","year":"2013","unstructured":"JT Bendor TP Logan RH Edwards 2013 The function of alpha-synuclein Neuron 79 6 1044 1066 https:\/\/doi.org\/10.1016\/j.neuron.2013.09.004","journal-title":"Neuron"},{"issue":"3","key":"5917_CR139","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1021\/bi026528t","volume":"42","author":"S Krishnan","year":"2003","unstructured":"Krishnan S, Chi EY, Wood SJ, Kendrick BS, Li C, Garzon-Rodriguez W, Wypych J, Randolph TW et al (2003) Oxidative dimer formation is the critical rate-limiting step for Parkinson's disease alpha-synuclein fibrillogenesis. Biochemistry 42 (3):829-837. https:\/\/doi.org\/10.1021\/bi026528t","journal-title":"Biochemistry"},{"issue":"8","key":"5917_CR140","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/S2215-0366(15)00232-1","volume":"2","author":"M Spies","year":"2015","unstructured":"M Spies GM Knudsen R Lanzenberger S Kasper 2015 The serotonin transporter in psychiatric disorders: insights from PET imaging Lancet Psychiatry 2 8 743 755 https:\/\/doi.org\/10.1016\/S2215-0366(15)00232-1","journal-title":"Lancet Psychiatry"},{"issue":"7","key":"5917_CR141","doi-asserted-by":"publisher","DOI":"10.3390\/metabo14070352","volume":"14","author":"C Sanluca","year":"2024","unstructured":"Sanluca C, Spagnolo P, Mancinelli R, De Bartolo MI, Fava M, Maccarrone M, Carotti S, Gaudio E et al (2024) Interaction between alpha-Synuclein and Bioactive Lipids: Neurodegeneration, Disease Biomarkers and Emerging Therapies. Metabolites 14 (7):352.https:\/\/doi.org\/10.3390\/metabo14070352","journal-title":"Metabolites"},{"key":"5917_CR142","doi-asserted-by":"publisher","unstructured":"Burre J, Sharma M, Sudhof TC (2018) Cell Biology and Pathophysiology of alpha-Synuclein. Cold Spring Harb Perspect Med 8(3). https:\/\/doi.org\/10.1101\/cshperspect.a024091","DOI":"10.1101\/cshperspect.a024091"},{"issue":"3","key":"5917_CR143","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.cell.2005.09.028","volume":"123","author":"S Chandra","year":"2005","unstructured":"S Chandra G Gallardo R Fernandez-Chacon OM Schluter TC Sudhof 2005 Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration Cell 123 3 383 396 https:\/\/doi.org\/10.1016\/j.cell.2005.09.028","journal-title":"Cell"},{"issue":"4","key":"5917_CR144","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1111\/jnc.14573","volume":"147","author":"JI Gallea","year":"2018","unstructured":"JI Gallea EE Ambroggio AA Vilcaes NG James DM Jameson MS Celej 2018 Amyloid oligomerization of the Parkinson\u2019s disease related protein alpha-synuclein impacts on its curvature-membrane sensitivity J Neurochem 147 4 541 556 https:\/\/doi.org\/10.1111\/jnc.14573","journal-title":"J Neurochem"},{"issue":"35","key":"5917_CR145","doi-asserted-by":"publisher","first-page":"23542","DOI":"10.1074\/jbc.M801992200","volume":"283","author":"T Vogiatzi","year":"2008","unstructured":"T Vogiatzi M Xilouri K Vekrellis L Stefanis 2008 Wild type alpha-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells J Biol Chem 283 35 23542 23556 https:\/\/doi.org\/10.1074\/jbc.M801992200","journal-title":"J Biol Chem"},{"key":"5917_CR146","doi-asserted-by":"publisher","first-page":"19573","DOI":"10.1073\/PNAS.1005005107","volume":"107","author":"B Greten-Harrison","year":"2010","unstructured":"Greten-Harrison B, Polydoro M, Morimoto-Tomita M, Diao L, Williams AM, Nie EH, Makani S, Tian N, et al. (2010) \u03b1\u03b2\u03b3-Synuclein triple knockout mice revealage-dependent neuronal dysfunction. Proc Natl Acad Sci U S A 107:19573\u201319578. https:\/\/doi.org\/10.1073\/PNAS.1005005107","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5917_CR147","doi-asserted-by":"publisher","unstructured":"Feller B, Fallon A, Luo W, Nguyen PT, Shlaifer I, Lee AK, Chofflet N, Yi N et al (2023) alpha-Synuclein Preformed Fibrils Bind to beta-Neurexins and Impair beta-Neurexin-Mediated Presynaptic Organization. Cells 12 (7). https:\/\/doi.org\/10.3390\/cells12071083","DOI":"10.3390\/cells12071083"},{"issue":"9","key":"5917_CR148","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1073\/pnas.1200575109","volume":"109","author":"M Lundblad","year":"2012","unstructured":"M Lundblad M Decressac B Mattsson A Bjorklund 2012 Impaired neurotransmission caused by overexpression of alpha-synuclein in nigral dopamine neurons Proc Natl Acad Sci U S A 109 9 3213 3219 https:\/\/doi.org\/10.1073\/pnas.1200575109","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Pt 5","key":"5917_CR149","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1093\/brain\/awu057","volume":"137","author":"E Rockenstein","year":"2014","unstructured":"Rockenstein E, Nuber S, Overk CR, Ubhi K, Mante M, Patrick C, Adame A, Trejo-Morales M, et al. (2014) Accumulation of oligomer-prone alpha-synuclein exacerbates synaptic and neuronal degeneration in vivo. Brain 137(Pt 5):1496\u20131513. https:\/\/doi.org\/10.1093\/brain\/awu057","journal-title":"Brain"},{"issue":"Pt 9","key":"5917_CR150","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1093\/brain\/awu193","volume":"137","author":"H Hall","year":"2014","unstructured":"H Hall S Reyes N Landeck C Bye G Leanza K Double L Thompson G Halliday D Kirik 2014 Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson\u2019s disease Brain 137 Pt 9 2493 2508 https:\/\/doi.org\/10.1093\/brain\/awu193","journal-title":"Brain"},{"issue":"3","key":"5917_CR151","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1002\/hbm.20035","volume":"22","author":"K Varnas","year":"2004","unstructured":"K Varnas C Halldin H Hall 2004 Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain Hum Brain Mapp 22 3 246 260 https:\/\/doi.org\/10.1002\/hbm.20035","journal-title":"Hum Brain Mapp"},{"issue":"5","key":"5917_CR152","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/nrgastro.2012.32","volume":"9","author":"JB Furness","year":"2012","unstructured":"JB Furness 2012 The enteric nervous system and neurogastroenterology Nat Rev Gastroenterol Hepatol 9 5 286 294 https:\/\/doi.org\/10.1038\/nrgastro.2012.32","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"5917_CR153","unstructured":"Gershon MD (1998) The second brain : the scientific basis of gut instinct and a groundbreaking new understanding of nervous disorders of the stomach and intestine.314"},{"key":"5917_CR154","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1146\/annurev.pa.29.040189.002053","volume":"29","author":"DT Monaghan","year":"1989","unstructured":"DT Monaghan RJ Bridges CW Cotman 1989 The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system Annu Rev Pharmacol Toxicol 29 365 402 https:\/\/doi.org\/10.1146\/annurev.pa.29.040189.002053","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"5917_CR155","unstructured":"Makhijani P (2024) Investigating the impact of distinct intercellular communication pathways in chronic inflammation. University of Toronto. http:\/\/hdl.handle.net\/1807\/140181"},{"issue":"10","key":"5917_CR156","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/nrn3346","volume":"13","author":"JF Cryan","year":"2012","unstructured":"JF Cryan TG Dinan 2012 Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour Nat Rev Neurosci 13 10 701 712 https:\/\/doi.org\/10.1038\/nrn3346","journal-title":"Nat Rev Neurosci"},{"issue":"6","key":"5917_CR157","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1002\/cne.21874","volume":"511","author":"S Liu","year":"2008","unstructured":"S Liu MH Qu W Ren HZ Hu N Gao GD Wang XY Wang G Fei F Zuo Y Xia JD Wood 2008 Differential expression of canonical (classical) transient receptor potential channels in guinea pig enteric nervous system J Comp Neurol 511 6 847 862 https:\/\/doi.org\/10.1002\/cne.21874","journal-title":"J Comp Neurol"},{"issue":"2","key":"5917_CR158","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.neuroscience.2006.12.017","volume":"145","author":"KB Neal","year":"2007","unstructured":"KB Neal JC Bornstein 2007 Mapping 5-HT inputs to enteric neurons of the guinea-pig small intestine Neuroscience 145 2 556 567 https:\/\/doi.org\/10.1016\/j.neuroscience.2006.12.017","journal-title":"Neuroscience"},{"issue":"3","key":"5917_CR159","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41593-020-0589-7","volume":"23","author":"C Challis","year":"2020","unstructured":"Challis C, Hori A, Sampson TR, Yoo BB, Challis RC, Hamilton AM, Mazmanian SK, Volpicelli-Daley LA et al (2020) Gut-seeded alpha-synuclein fibrils promote gut dysfunction and brain pathology specifically in aged mice. Nat Neurosci 23 (3):327-336.https:\/\/doi.org\/10.1038\/s41593-020-0589-7","journal-title":"Nat Neurosci"},{"key":"5917_CR160","doi-asserted-by":"publisher","unstructured":"Dierckx RAJO, Otte A, de Vries EFJ, van Waarde A (2020) PET and SPECT in neurology. PET and SPECT in Neurology:1\u20131289. https:\/\/doi.org\/10.1007\/978-3-030-53168-3\/COVER","DOI":"10.1007\/978-3-030-53168-3\/COVER"},{"issue":"6","key":"5917_CR161","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s00401-014-1343-6","volume":"128","author":"S Holmqvist","year":"2014","unstructured":"Holmqvist S, Chutna O, Bousset L, Aldrin-Kirk P, Li W, Bjorklund T, Wang ZY, Roybon L et al (2014) Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathol 128 (6):805-820. https:\/\/doi.org\/10.1007\/s00401-014-1343-6","journal-title":"Acta Neuropathol"},{"key":"5917_CR162","doi-asserted-by":"publisher","unstructured":"Srivastava A, Kataria A, Yadav DK, Han I, Choi EH (2022) Interplay of alpha-synuclein pathology and gut microbiome in Parkinson\u2019s disease. Human-Gut Microbiome: Establishment and Interactions:159\u2013178. https:\/\/doi.org\/10.1016\/B978-0-323-91313-3.00003-9","DOI":"10.1016\/B978-0-323-91313-3.00003-9"},{"issue":"1","key":"5917_CR163","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/mds.27138","volume":"33","author":"P Borghammer","year":"2018","unstructured":"P Borghammer 2018 How does Parkinson\u2019s disease begin? Perspectives on neuroanatomical pathways, prions, and histology Mov Disord 33 1 48 57 https:\/\/doi.org\/10.1002\/mds.27138","journal-title":"Mov Disord"},{"issue":"10","key":"5917_CR164","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1093\/brain\/awaa238","volume":"143","author":"J Horsager","year":"2020","unstructured":"Horsager J, Andersen KB, Knudsen K, Skjaerbaek C, Fedorova TD, Okkels N, Schaeffer E, Bonkat SK et al (2020) Brain-first versus body-first Parkinson's disease: a multimodal imaging case-control study. Brain 143 (10):3077-3088. https:\/\/doi.org\/10.1093\/brain\/awaa238","journal-title":"Brain"},{"key":"5917_CR165","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3389\/fnins.2019.00369","volume":"13","author":"E Fitzgerald","year":"2019","unstructured":"E Fitzgerald S Murphy HA Martinson 2019 Alpha-synuclein pathology and the role of the microbiota in Parkinson\u2019s disease Front Neurosci 13 369 https:\/\/doi.org\/10.3389\/fnins.2019.00369","journal-title":"Front Neurosci"},{"key":"5917_CR166","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-020-0112-6","volume":"6","author":"ZD Wallen","year":"2020","unstructured":"Wallen ZD, Appah M, Dean MN, Sesler CL, Factor SA, Molho E, Zabetian CP, Standaert DG et al (2020) Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens. NPJ Parkinsons Dis 6:11. https:\/\/doi.org\/10.1038\/s41531-020-0112-6","journal-title":"npj Parkinsons Dis"},{"key":"5917_CR167","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.01399","volume":"13","author":"LD Bernal-Conde","year":"2019","unstructured":"LD Bernal-Conde R Ramos-Acevedo MA Reyes-Hernandez AJ Balbuena-Olvera ID Morales-Moreno R Arguero-Sanchez B Schule M Guerra-Crespo 2019 Alpha-synuclein physiology and pathology: a perspective on cellular structures and organelles Front Neurosci 13 1399https:\/\/doi.org\/10.3389\/fnins.2019.01399","journal-title":"Front Neurosci"},{"key":"5917_CR168","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105654","volume":"166","author":"A Kasen","year":"2022","unstructured":"A Kasen C Houck AR Burmeister Q Sha L Brundin P Brundin 2022 Upregulation of alpha-synuclein following immune activation: possible trigger of Parkinson\u2019s disease Neurobiol Dis 166 105654https:\/\/doi.org\/10.1016\/j.nbd.2022.105654","journal-title":"Neurobiol Dis"},{"issue":"Suppl 4","key":"5917_CR169","doi-asserted-by":"publisher","first-page":"iv15","DOI":"10.1136\/gut.47.suppl_4.iv15","volume":"47","author":"M Costa","year":"2000","unstructured":"Costa M, Brookes SJ, Hennig GW (2000) Anatomy and physiology of the enteric nervous system. Gut 47(Suppl 4):iv15-19. https:\/\/doi.org\/10.1136\/gut.47.suppl_4.iv15","journal-title":"Gut"},{"key":"5917_CR170","doi-asserted-by":"publisher","unstructured":"Ortiz de Ora L, Uyeda KS, Bess E (2022) Discovery of a gut bacterial metabolic pathway that Drives \u03b1-Synuclein aggregation and neurodegeneration. https:\/\/doi.org\/10.1101\/2022.06.08.495350","DOI":"10.1101\/2022.06.08.495350"},{"issue":"4","key":"5917_CR171","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1021\/acschembio.4c00095","volume":"19","author":"L Ortiz de Ora","year":"2024","unstructured":"Ortiz de Ora L, Balsamo JM, Uyeda KS, Bess EN (2024) Discovery of a gut bacterial metabolic pathway that drives alpha-Synuclein aggregation. ACS Chem Biol 19(4):1011\u20131021. https:\/\/doi.org\/10.1021\/acschembio.4c00095","journal-title":"ACS Chem Biol"},{"issue":"13","key":"5917_CR172","doi-asserted-by":"publisher","first-page":"6661","DOI":"10.1021\/cr400695p","volume":"114","author":"FX Theillet","year":"2014","unstructured":"Theillet FX, Binolfi A, Frembgen-Kesner T, Hingorani K, Sarkar M, Kyne C, Li C, Crowley PB et al (2014) Physicochemical properties of cells and their effects on intrinsically disordered proteins (IDPs). Chem Rev 114 (13):6661-6714. https:\/\/doi.org\/10.1021\/cr400695p","journal-title":"Chem Rev"},{"issue":"Pt 4","key":"5917_CR173","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/brain\/aww022","volume":"139","author":"DJ Hare","year":"2016","unstructured":"DJ Hare KL Double 2016 Iron and dopamine: a toxic couple Brain 139 Pt 4 1026 1035 https:\/\/doi.org\/10.1093\/brain\/aww022","journal-title":"Brain"},{"issue":"47","key":"5917_CR174","doi-asserted-by":"publisher","first-page":"44284","DOI":"10.1074\/jbc.M105343200","volume":"276","author":"VN Uversky","year":"2001","unstructured":"VN Uversky J Li AL Fink 2001 Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson\u2019s disease and heavy metal exposure J Biol Chem 276 47 44284 44296 https:\/\/doi.org\/10.1074\/jbc.M105343200","journal-title":"J Biol Chem"},{"key":"5917_CR175","doi-asserted-by":"crossref","unstructured":"Knowles SR, Keefer L, Mikocka-Walus AA (2020) Psychogastroenterology for adults: a handbook for mental health professionals, vol 1. Routledge, Taylor & Francis Group","DOI":"10.4324\/9780429203749"},{"key":"5917_CR176","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-016-0002-0","volume":"3","author":"MC Houser","year":"2017","unstructured":"Houser MC, Tansey MG (2017) The gut-brain axis: is intestinal inflammation a silent driver of Parkinson\u2019s disease pathogenesis? NPJ Parkinsons Dis 3:3. https:\/\/doi.org\/10.1038\/s41531-016-0002-0","journal-title":"NPJ Parkinsons Dis"},{"key":"5917_CR177","doi-asserted-by":"publisher","unstructured":"Pellegrini C, D\u2019Antongiovanni V, Ippolito C, Segnani C, Antonioli L, Fornai M, Bernardini N (2021) From the intestinal mucosal barrier to the enteric neuromuscular compartment: an integrated overview on the morphological changes in Parkinson\u2019s disease. Eur J Histochem 65(s1). https:\/\/doi.org\/10.4081\/ejh.2021.3278","DOI":"10.4081\/ejh.2021.3278"},{"issue":"9","key":"5917_CR178","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1093\/brain\/awab156","volume":"144","author":"Q Wang","year":"2021","unstructured":"Q Wang Y Luo K Ray Chaudhuri R Reynolds EK Tan S Pettersson 2021 The role of gut dysbiosis in Parkinson\u2019s disease: mechanistic insights and therapeutic options Brain 144 9 2571 2593 https:\/\/doi.org\/10.1093\/brain\/awab156","journal-title":"Brain"},{"issue":"10","key":"5917_CR179","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1002\/mds.26307","volume":"30","author":"A Keshavarzian","year":"2015","unstructured":"A Keshavarzian SJ Green PA Engen RM Voigt A Naqib CB Forsyth E Mutlu KM Shannon 2015 Colonic bacterial composition in Parkinson\u2019s disease Mov Disord 30 10 1351 1360 https:\/\/doi.org\/10.1002\/mds.26307","journal-title":"Mov Disord"},{"issue":"s2","key":"5917_CR180","doi-asserted-by":"publisher","first-page":"S297","DOI":"10.3233\/JPD-191711","volume":"9","author":"JM Boertien","year":"2019","unstructured":"JM Boertien PAB Pereira VTE Aho F Scheperjans 2019 Increasing comparability and utility of gut microbiome studies in Parkinson\u2019s disease: a systematic review J Parkinsons Dis 9 s2 S297 S312 https:\/\/doi.org\/10.3233\/JPD-191711","journal-title":"J Parkinsons Dis"},{"key":"5917_CR181","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.parkreldis.2019.06.003","volume":"65","author":"D Pietrucci","year":"2019","unstructured":"Pietrucci D, Cerroni R, Unida V, Farcomeni A, Pierantozzi M, Mercuri NB, Biocca S, Stefani A et al (2019) Dysbiosis of gut microbiota in a selected population of Parkinson's patients. Parkinsonism Relat Disord 65:124-130. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.06.003","journal-title":"Parkinsonism Relat Disord"},{"key":"5917_CR182","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2023.110668","volume":"199","author":"M Bourque","year":"2023","unstructured":"M Bourque M Morissette D Soulet T Di Paolo 2023 Impact of sex on neuroimmune contributions to Parkinson\u2019s disease Brain Res Bull 199 110668https:\/\/doi.org\/10.1016\/j.brainresbull.2023.110668","journal-title":"Brain Res Bull"},{"issue":"4","key":"5917_CR183","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1007\/s11011-018-0239-x","volume":"33","author":"X Fang","year":"2018","unstructured":"Fang X (2018) Impaired tissue barriers as potential therapeutic targets for Parkinson\u2019s disease and Amyotrophic Lateral Sclerosis. Metab Brain Dis 33(4):1031\u20131043. https:\/\/doi.org\/10.1007\/s11011-018-0239-x","journal-title":"Metab Brain Dis"},{"issue":"9","key":"5917_CR184","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1007\/s00415-019-09320-1","volume":"267","author":"M Lubomski","year":"2020","unstructured":"M Lubomski AH Tan SY Lim AJ Holmes RL Davis CM Sue 2020 Parkinson\u2019s disease and the gastrointestinal microbiome J Neurol 267 9 2507 2523 https:\/\/doi.org\/10.1007\/s00415-019-09320-1","journal-title":"J Neurol"},{"key":"5917_CR185","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.parkreldis.2016.08.019","volume":"32","author":"MM Unger","year":"2016","unstructured":"Unger MM, Spiegel J, Dillmann KU, Grundmann D, Philippeit H, Burmann J, Fassbender K, Schwiertz A et al (2016) Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls. Parkinsonism Relat Disord 32:66-72. https:\/\/doi.org\/10.1016\/j.parkreldis.2016.08.019","journal-title":"Parkinsonism Relat Disord"},{"key":"5917_CR186","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ejphar.2017.05.042","volume":"817","author":"P Perez-Pardo","year":"2017","unstructured":"P Perez-Pardo T Kliest HB Dodiya LM Broersen J Garssen A Keshavarzian AD Kraneveld 2017 The gut-brain axis in Parkinson\u2019s disease: possibilities for food-based therapies Eur J Pharmacol 817 86 95 https:\/\/doi.org\/10.1016\/j.ejphar.2017.05.042","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"5917_CR187","doi-asserted-by":"publisher","DOI":"10.1016\/j.aggp.2025.100142","volume":"2","author":"NV K","year":"2025","unstructured":"K NV, S M (2025) Aging through the lens of the gut microbiome: Challenges and therapeutic opportunities. Arch Gerontol Geriatr Plus 2(2):100142. https:\/\/doi.org\/10.1016\/j.aggp.2025.100142","journal-title":"Arch Gerontol Geriatr Plus"},{"key":"5917_CR188","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/B978-0-444-63945-5.00017-9","volume":"153","author":"L Volpicelli-Daley","year":"2018","unstructured":"L Volpicelli-Daley P Brundin 2018 Prion-like propagation of pathology in Parkinson disease Handb Clin Neurol 153 321 335 https:\/\/doi.org\/10.1016\/B978-0-444-63945-5.00017-9","journal-title":"Handb Clin Neurol"},{"issue":"7","key":"5917_CR189","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.tim.2017.11.002","volume":"26","author":"A Heintz-Buschart","year":"2018","unstructured":"A Heintz-Buschart P Wilmes 2018 Human gut microbiome: function matters Trends Microbiol 26 7 563 574 https:\/\/doi.org\/10.1016\/j.tim.2017.11.002","journal-title":"Trends Microbiol"},{"key":"5917_CR190","doi-asserted-by":"publisher","DOI":"10.1016\/j.npep.2025.102516","volume":"111","author":"MN Khan","year":"2025","unstructured":"MN Khan D Choudhary S Mehan Z Khan GD Gupta AS Narula 2025 Molecular mechanisms of GDNF\/GFRA1\/RET and PI3K\/AKT\/ERK signaling interplay in neuroprotection: therapeutic strategies for treating neurological disorders Neuropeptides 111 102516https:\/\/doi.org\/10.1016\/j.npep.2025.102516","journal-title":"Neuropeptides"},{"issue":"3","key":"5917_CR191","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00401-018-1856-5","volume":"136","author":"C Pellegrini","year":"2018","unstructured":"C Pellegrini L Antonioli R Colucci C Blandizzi M Fornai 2018 Interplay among gut microbiota, intestinal mucosal barrier and enteric neuro-immune system: a common path to neurodegenerative diseases? Acta Neuropathol 136 3 345 361 https:\/\/doi.org\/10.1007\/s00401-018-1856-5","journal-title":"Acta Neuropathol"},{"issue":"2","key":"5917_CR192","doi-asserted-by":"publisher","first-page":"233","DOI":"10.2174\/1570159X18666200606233050","volume":"19","author":"G Kaur","year":"2021","unstructured":"G Kaur T Behl S Bungau A Kumar MS Uddin V Mehta G Zengin B Mathew MA Shah S Arora 2021 Dysregulation of the gut-brain axis, dysbiosis and influence of numerous factors on gut microbiota associated Parkinson\u2019s disease Curr Neuropharmacol 19 2 233 247 https:\/\/doi.org\/10.2174\/1570159X18666200606233050","journal-title":"Curr Neuropharmacol"},{"key":"5917_CR193","doi-asserted-by":"crossref","unstructured":"Rajagopal S, Essa MM, Ramachandran S, Sundararaman G, Alharbi HF (2024) In: Nutrition and obsessive-compulsive disorder: the interplay, 1st edn. CRC Press","DOI":"10.1201\/9781003387893"},{"issue":"6","key":"5917_CR194","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1011456","volume":"19","author":"S Vascellari","year":"2023","unstructured":"Vascellari S, Orru CD, Groveman BR, Parveen S, Fenu G, Pisano G, Piga G, Serra G et al (2023) alpha-Synuclein seeding activity in duodenum biopsies from Parkinson's disease patients. PLoS Pathog 19 (6):e1011456. https:\/\/doi.org\/10.1371\/journal.ppat.1011456","journal-title":"PLoS Pathog"},{"issue":"6","key":"5917_CR195","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1002\/ana.24648","volume":"79","author":"MG Stokholm","year":"2016","unstructured":"MG Stokholm EH Danielsen SJ Hamilton-Dutoit P Borghammer 2016 Pathological alpha-synuclein in gastrointestinal tissues from prodromal Parkinson disease patients Ann Neurol 79 6 940 949 https:\/\/doi.org\/10.1002\/ana.24648","journal-title":"Ann Neurol"},{"key":"5917_CR196","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.nbd.2012.09.007","volume":"50","author":"D Devos","year":"2013","unstructured":"Devos D, Lebouvier T, Lardeux B, Biraud M, Rouaud T, Pouclet H, Coron E, Bruley des Varannes S, et al. (2013) Colonic inflammation in Parkinson\u2019s disease. Neurobiol Dis 50:42\u201348. https:\/\/doi.org\/10.1016\/j.nbd.2012.09.007","journal-title":"Neurobiol Dis"},{"key":"5917_CR197","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19061689","author":"V Caputi","year":"2018","unstructured":"V Caputi MC Giron 2018 Microbiome-gut-brain axis and toll-like receptors in Parkinson\u2019s disease Int J Mol Sci https:\/\/doi.org\/10.3390\/ijms19061689","journal-title":"Int J Mol Sci"},{"issue":"2","key":"5917_CR198","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/MOG.0000000000000040","volume":"30","author":"EM Quigley","year":"2014","unstructured":"EM Quigley 2014 Small intestinal bacterial overgrowth: what it is and what it is not Curr Opin Gastroenterol 30 2 141 146 https:\/\/doi.org\/10.1097\/MOG.0000000000000040","journal-title":"Curr Opin Gastroenterol"},{"issue":"6","key":"5917_CR199","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1096\/fj.04-2751com","volume":"19","author":"W Zhang","year":"2005","unstructured":"Zhang W, Wang T, Pei Z, Miller DS, Wu X, Block ML, Wilson B, Zhang W et al (2005) Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease. FASEB J 19 (6):533-542. https:\/\/doi.org\/10.1096\/fj.04-2751com","journal-title":"FASEB J"},{"issue":"9","key":"5917_CR200","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1002\/mds.25522","volume":"28","author":"A Fasano","year":"2013","unstructured":"Fasano A, Bove F, Gabrielli M, Petracca M, Zocco MA, Ragazzoni E, Barbaro F, Piano C, et al. (2013) The role of small intestinal bacterial overgrowth in Parkinson\u2019s disease. Mov Disord 28(9):1241\u20131249. https:\/\/doi.org\/10.1002\/mds.25522","journal-title":"Mov Disord"},{"issue":"5","key":"5917_CR201","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/mds.23566","volume":"26","author":"M Gabrielli","year":"2011","unstructured":"Gabrielli M, Bonazzi P, Scarpellini E, Bendia E, Lauritano EC, Fasano A, Ceravolo MG, Capecci M et al (2011) Prevalence of small intestinal bacterial overgrowth in Parkinson\u2019s disease. Mov Disord 26(5):889\u2013892. https:\/\/doi.org\/10.1002\/mds.23566","journal-title":"Mov Disord"},{"issue":"8","key":"5917_CR202","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/jnnp-2019-322338","volume":"91","author":"J Jankovic","year":"2020","unstructured":"J Jankovic EK Tan 2020 Parkinson\u2019s disease: etiopathogenesis and treatment J Neurol Neurosurg Psychiatry 91 8 795 808 https:\/\/doi.org\/10.1136\/jnnp-2019-322338","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"s1","key":"5917_CR203","doi-asserted-by":"publisher","first-page":"S113","DOI":"10.3233\/JPD-223338","volume":"12","author":"S Jewell","year":"2022","unstructured":"S Jewell AM Herath R Gordon 2022 Inflammasome activation in Parkinson\u2019s disease J Parkinsons Dis 12 s1 S113 S128 https:\/\/doi.org\/10.3233\/JPD-223338","journal-title":"J Parkinsons Dis"},{"issue":"5","key":"5917_CR204","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1111\/apt.13928","volume":"45","author":"L Gatta","year":"2017","unstructured":"L Gatta C Scarpignato 2017 Systematic review with meta-analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth Aliment Pharmacol Ther 45 5 604 616 https:\/\/doi.org\/10.1111\/apt.13928","journal-title":"Aliment Pharmacol Ther"},{"key":"5917_CR205","doi-asserted-by":"crossref","unstructured":"Seo H, Yang C, Kim H-S, Kim K-S (1996) Multiple protein factors interact with the cis-regulatory elements of the proximal promoter in a cell-specific manner and regulate transcription of the dopamine-hydroxylase gene","DOI":"10.1523\/JNEUROSCI.16-13-04102.1996"},{"key":"5917_CR206","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/B978-0-12-819410-2.00023-0","volume":"184","author":"F Garretti","year":"2022","unstructured":"F Garretti C Monahan A Sette D Agalliu D Sulzer 2022 T cells, alpha-synuclein and Parkinson disease Handb Clin Neurol 184 439 455 https:\/\/doi.org\/10.1016\/B978-0-12-819410-2.00023-0","journal-title":"Handb Clin Neurol"},{"issue":"1","key":"5917_CR207","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1136\/gutjnl-2017-315666","volume":"68","author":"M Villumsen","year":"2019","unstructured":"M Villumsen S Aznar B Pakkenberg T Jess T Brudek 2019 Inflammatory bowel disease increases the risk of Parkinson\u2019s disease: a Danish nationwide cohort study 1977\u20132014 Gut 68 1 18 24 https:\/\/doi.org\/10.1136\/gutjnl-2017-315666","journal-title":"Gut"},{"key":"5917_CR208","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2024.1432659","volume":"18","author":"Y Fu","year":"2024","unstructured":"Y Fu Z Gu H Cao C Zuo Y Huang Y Song Y Jiang F Wang 2024 The role of the gut microbiota in neurodegenerative diseases targeting metabolism Front Neurosci 18 1432659https:\/\/doi.org\/10.3389\/fnins.2024.1432659","journal-title":"Front Neurosci"},{"key":"5917_CR209","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.13570","author":"MJ Benskey","year":"2016","unstructured":"MJ Benskey RG Perez FP Manfredsson 2016 The contribution of alpha synuclein to neuronal survival and function - implications for Parkinson\u2019s disease J Neurochem https:\/\/doi.org\/10.1111\/jnc.13570","journal-title":"J Neurochem"},{"key":"5917_CR210","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2024.117183","volume":"286","author":"Y Ren","year":"2024","unstructured":"Ren Y, Wu K, He Y, Zhang H, Ma J, Li C, Ruan Y, Zhang J et al (2024) The role of NLRP3 inflammasome-mediated neuroinflammation in chronic noise-induced impairment of learning and memory ability. Ecotoxicol Environ Saf 286:117183. https:\/\/doi.org\/10.1016\/j.ecoenv.2024.117183","journal-title":"Ecotoxicol Environ Saf"},{"key":"5917_CR211","doi-asserted-by":"publisher","unstructured":"Dodiya HB, Lutz HL, Weigle IQ, Patel P, Michalkiewicz J, Roman-Santiago CJ, Zhang CM, Liang Y et al (2022) Gut microbiota-driven brain Abeta amyloidosis in mice requires microglia. J Exp Med 219 (1). https:\/\/doi.org\/10.1084\/jem.20200895","DOI":"10.1084\/jem.20200895"},{"key":"5917_CR212","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.parkreldis.2018.02.022","volume":"50","author":"A Schwiertz","year":"2018","unstructured":"A Schwiertz J Spiegel U Dillmann D Grundmann J Burmann K Fassbender KH Schafer MM Unger 2018 Fecal markers of intestinal inflammation and intestinal permeability are elevated in Parkinson\u2019s disease Parkinsonism Relat Disord 50 104 107 https:\/\/doi.org\/10.1016\/j.parkreldis.2018.02.022","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"5917_CR213","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/ejn.14290","volume":"49","author":"MG Tansey","year":"2019","unstructured":"MG Tansey M Romero-Ramos 2019 Immune system responses in Parkinson\u2019s disease: early and dynamic Eur J Neurosci 49 3 364 383 https:\/\/doi.org\/10.1111\/ejn.14290","journal-title":"Eur J Neurosci"},{"issue":"1","key":"5917_CR214","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-024-00724-z","volume":"10","author":"H Nishiwaki","year":"2024","unstructured":"Nishiwaki H, Ueyama J, Ito M, Hamaguchi T, Takimoto K, Maeda T, Kashihara K, Tsuboi Y et al (2024) Meta-analysis of shotgun sequencing of gut microbiota in Parkinson\u2019s disease. npj Park Dis 10(1):106. https:\/\/doi.org\/10.1038\/s41531-024-00724-z","journal-title":"npj Park Dis"},{"key":"5917_CR215","doi-asserted-by":"publisher","unstructured":"Gut Microbiota in Aging and Chronic Diseases (2023). 17. https:\/\/doi.org\/10.1007\/978-3-031-14023-5","DOI":"10.1007\/978-3-031-14023-5"},{"key":"5917_CR216","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.bbi.2018.02.005","volume":"70","author":"MF Sun","year":"2018","unstructured":"MF Sun YL Zhu ZL Zhou XB Jia YD Xu Q Yang C Cui YQ Shen 2018 Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson\u2019s disease mice: gut microbiota, glial reaction and TLR4\/TNF-alpha signaling pathway Brain Behav Immun 70 48 60 https:\/\/doi.org\/10.1016\/j.bbi.2018.02.005","journal-title":"Brain Behav Immun"},{"key":"5917_CR217","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.arr.2018.04.004","volume":"45","author":"MF Sun","year":"2018","unstructured":"MF Sun YQ Shen 2018 Dysbiosis of gut microbiota and microbial metabolites in Parkinson\u2019s disease Ageing Res Rev 45 53 61 https:\/\/doi.org\/10.1016\/j.arr.2018.04.004","journal-title":"Ageing Res Rev"},{"key":"5917_CR218","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00025","volume":"11","author":"YP Silva","year":"2020","unstructured":"Silva YP, Bernardi A, Frozza RL (2020) The role of short-chain fatty acids from gut microbiota in gut-brain communication. Front Endocrinol (Lausanne) 11:25. https:\/\/doi.org\/10.3389\/fendo.2020.00025","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"5917_CR219","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41575-019-0157-3","volume":"16","author":"B Dalile","year":"2019","unstructured":"B Dalile L Oudenhove Van B Vervliet K Verbeke 2019 The role of short-chain fatty acids in microbiota-gut-brain communication Nat Rev Gastroenterol Hepatol 16 8 461 478 https:\/\/doi.org\/10.1038\/s41575-019-0157-3","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"5917_CR220","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1017\/S0029665120006916","volume":"80","author":"C Martin-Gallausiaux","year":"2021","unstructured":"C Martin-Gallausiaux L Marinelli HM Blottiere P Larraufie N Lapaque 2021 SCFA: mechanisms and functional importance in the gut Proc Nutr Soc 80 1 37 49 https:\/\/doi.org\/10.1017\/S0029665120006916","journal-title":"Proc Nutr Soc"},{"key":"5917_CR221","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/bs.pbr.2020.01.004","volume":"252","author":"A Keshavarzian","year":"2020","unstructured":"A Keshavarzian P Engen S Bonvegna R Cilia 2020 The gut microbiome in Parkinson\u2019s disease: a culprit or a bystander? Prog Brain Res 252 357 450 https:\/\/doi.org\/10.1016\/bs.pbr.2020.01.004","journal-title":"Prog Brain Res"},{"key":"5917_CR222","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00277","volume":"10","author":"D Parada Venegas","year":"2019","unstructured":"Parada Venegas D, De la Fuente MK, Landskron G, Gonzalez MJ, Quera R, Dijkstra G, Harmsen HJM, Faber KN, et al. (2019) Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Front Immunol 10:277. https:\/\/doi.org\/10.3389\/fimmu.2019.00277","journal-title":"Front Immunol"},{"key":"5917_CR223","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.ebiom.2018.03.030","volume":"30","author":"G Chen","year":"2018","unstructured":"G Chen X Ran B Li Y Li D He B Huang S Fu J Liu W Wang 2018 Sodium butyrate inhibits inflammation and maintains epithelium barrier integrity in a TNBS-induced inflammatory bowel disease mice model EBioMedicine 30 317 325 https:\/\/doi.org\/10.1016\/j.ebiom.2018.03.030","journal-title":"EBioMedicine"},{"issue":"1","key":"5917_CR224","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.cmet.2019.10.005","volume":"31","author":"NK Das","year":"2020","unstructured":"Das NK, Schwartz AJ, Barthel G, Inohara N, Liu Q, Sankar A, Hill DR, Ma X, et al. (2020) Microbial metabolite signaling is required for systemic iron homeostasis. Cell Metab 31(1):115\u2013130. https:\/\/doi.org\/10.1016\/j.cmet.2019.10.005","journal-title":"Cell Metab"},{"issue":"5","key":"5917_CR225","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41574-019-0156-z","volume":"15","author":"EE Canfora","year":"2019","unstructured":"EE Canfora RCR Meex K Venema EE Blaak 2019 Gut microbial metabolites in obesity, NAFLD and T2DM Nat Rev Endocrinol 15 5 261 273 https:\/\/doi.org\/10.1038\/s41574-019-0156-z","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"5917_CR226","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.chom.2015.03.005","volume":"17","author":"CJ Kelly","year":"2015","unstructured":"Kelly CJ, Zheng L, Campbell EL, Saeedi B, Scholz CC, Bayless AJ, Wilson KE, Glover LE et al (2015) Crosstalk between Microbiota-Derived Short-Chain Fatty Acids and Intestinal Epithelial HIF Augments Tissue Barrier Function. Cell Host Microbe 17 (5):662-671. https:\/\/doi.org\/10.1016\/j.chom.2015.03.005","journal-title":"Cell Host Microbe"},{"issue":"2","key":"5917_CR227","doi-asserted-by":"publisher","first-page":"92","DOI":"10.14802\/jmd.15003","volume":"8","author":"HM Lee","year":"2015","unstructured":"HM Lee SB Koh 2015 Many faces of Parkinson\u2019s disease: non-motor symptoms of Parkinson\u2019s disease J Mov Disord 8 2 92 97 https:\/\/doi.org\/10.14802\/jmd.15003","journal-title":"J Mov Disord"},{"issue":"12","key":"5917_CR228","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1093\/hmg\/ddx114","volume":"26","author":"I Paiva","year":"2017","unstructured":"Paiva I, Pinho R, Pavlou MA, Hennion M, Wales P, Schutz AL, Rajput A, Szego EM et al (2017) Sodium butyrate rescues dopaminergic cells from alpha-synuclein-induced transcriptional deregulation and DNA damage. Hum Mol Genet 26 (12):2231-2246. https:\/\/doi.org\/10.1093\/hmg\/ddx114","journal-title":"Hum Mol Genet"},{"issue":"4","key":"5917_CR229","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1152\/physrev.00018.2018","volume":"99","author":"JF Cryan","year":"2019","unstructured":"Cryan JF, O'Riordan KJ, Cowan CSM, Sandhu KV, Bastiaanssen TFS, Boehme M, Codagnone MG, Cussotto S et al (2019) The Microbiota-Gut-Brain Axis. Physiol Rev 99 (4):1877-2013. https:\/\/doi.org\/10.1152\/physrev.00018.2018","journal-title":"Physiol Rev"},{"issue":"2","key":"5917_CR230","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.cell.2015.02.047","volume":"161","author":"JM Yano","year":"2015","unstructured":"Yano JM, Yu K, Donaldson GP, Shastri GG, Ann P, Ma L, Nagler CR, Ismagilov RF et al (2015) Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell 161 (2):264-276. https:\/\/doi.org\/10.1016\/j.cell.2015.02.047","journal-title":"Cell"},{"key":"5917_CR231","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.bbr.2014.07.027","volume":"277","author":"SM O\u2019Mahony","year":"2015","unstructured":"SM O\u2019Mahony G Clarke YE Borre TG Dinan JF Cryan 2015 Serotonin, tryptophan metabolism and the brain-gut-microbiome axis Behav Brain Res 277 32 48 https:\/\/doi.org\/10.1016\/j.bbr.2014.07.027","journal-title":"Behav Brain Res"},{"key":"5917_CR232","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1146\/annurev.med.60.042307.110802","volume":"60","author":"M Berger","year":"2009","unstructured":"M Berger JA Gray BL Roth 2009 The expanded biology of serotonin Annu Rev Med 60 355 366 https:\/\/doi.org\/10.1146\/annurev.med.60.042307.110802","journal-title":"Annu Rev Med"},{"issue":"1","key":"5917_CR233","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/MED.0b013e32835bc703","volume":"20","author":"MD Gershon","year":"2013","unstructured":"MD Gershon 2013 5-Hydroxytryptamine (serotonin) in the gastrointestinal tract Curr Opin Endocrinol Diabetes Obes 20 1 14 21 https:\/\/doi.org\/10.1097\/MED.0b013e32835bc703","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"8","key":"5917_CR234","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1210\/me.2014-1108","volume":"28","author":"G Clarke","year":"2014","unstructured":"G Clarke RM Stilling PJ Kennedy C Stanton JF Cryan TG Dinan 2014 Minireview: gut microbiota: the neglected endocrine organ Mol Endocrinol 28 8 1221 1238 https:\/\/doi.org\/10.1210\/me.2014-1108","journal-title":"Mol Endocrinol"},{"issue":"Pt B","key":"5917_CR235","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.neuropharm.2016.07.002","volume":"112","author":"PJ Kennedy","year":"2017","unstructured":"PJ Kennedy JF Cryan TG Dinan G Clarke 2017 Kynurenine pathway metabolism and the microbiota-gut-brain axis Neuropharmacology 112 Pt B 399 412 https:\/\/doi.org\/10.1016\/j.neuropharm.2016.07.002","journal-title":"Neuropharmacology"},{"issue":"12","key":"5917_CR236","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1212\/WNL.0000000000002494","volume":"86","author":"AA Roussakis","year":"2016","unstructured":"AA Roussakis M Politis D Towey P Piccini 2016 Serotonin-to-dopamine transporter ratios in Parkinson disease: relevance for dyskinesias Neurology 86 12 1152 1158 https:\/\/doi.org\/10.1212\/WNL.0000000000002494","journal-title":"Neurology"},{"issue":"2","key":"5917_CR237","doi-asserted-by":"publisher","DOI":"10.3390\/foods12020320","volume":"12","author":"HH Xiong","year":"2023","unstructured":"HH Xiong SY Lin LL Chen KH Ouyang WJ Wang 2023 The interaction between flavonoids and intestinal microbes: a review Foods 12 2 320https:\/\/doi.org\/10.3390\/foods12020320","journal-title":"Foods"},{"issue":"2","key":"5917_CR238","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.pneurobio.2011.08.004","volume":"95","author":"P Huot","year":"2011","unstructured":"P Huot SH Fox JM Brotchie 2011 The serotonergic system in Parkinson\u2019s disease Prog Neurobiol 95 2 163 212 https:\/\/doi.org\/10.1016\/j.pneurobio.2011.08.004","journal-title":"Prog Neurobiol"},{"issue":"15","key":"5917_CR239","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1212\/01.wnl.0000340980.19702.6e","volume":"72","author":"RB Postuma","year":"2009","unstructured":"RB Postuma JF Gagnon M Vendette ML Fantini J Massicotte-Marquez J Montplaisir 2009 Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder Neurology 72 15 1296 1300 https:\/\/doi.org\/10.1212\/01.wnl.0000340980.19702.6e","journal-title":"Neurology"},{"key":"5917_CR240","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.01934","volume":"7","author":"R Mazzoli","year":"2016","unstructured":"Mazzoli R, Pessione E (2016) The neuro-endocrinological role of microbial Glutamate and GABA signaling. Front Microbiol 7:1934. https:\/\/doi.org\/10.3389\/fmicb.2016.01934","journal-title":"Front Microbiol"},{"issue":"4","key":"5917_CR241","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s11604-019-00901-8","volume":"38","author":"T Kaneta","year":"2020","unstructured":"T Kaneta 2020 PET and SPECT imaging of the brain: a review on the current status of nuclear medicine in Japan Jpn J Radiol 38 4 343 357 https:\/\/doi.org\/10.1007\/s11604-019-00901-8","journal-title":"Jpn J Radiol"},{"issue":"38","key":"5917_CR242","doi-asserted-by":"publisher","first-page":"16050","DOI":"10.1073\/pnas.1102999108","volume":"108","author":"JA Bravo","year":"2011","unstructured":"Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG, Bienenstock J, Cryan JF (2011) Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A 108(38):16050\u201316055. https:\/\/doi.org\/10.1073\/pnas.1102999108","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"5917_CR243","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41564-018-0307-3","volume":"4","author":"P Strandwitz","year":"2019","unstructured":"Strandwitz P, Kim KH, Terekhova D, Liu JK, Sharma A, Levering J, McDonald D, Dietrich D et al (2019) GABA-modulating bacteria of the human gut microbiota. Nat Microbiol 4 (3):396-403. https:\/\/doi.org\/10.1038\/s41564-018-0307-3","journal-title":"Nat Microbiol"},{"issue":"1","key":"5917_CR244","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1186\/s12964-025-02393-8","volume":"23","author":"X Fan","year":"2025","unstructured":"X Fan Z Xiao Y Chen H Yang M Diao W Hu S Wang 2025 Interactions between gut microbiota and Parkinson\u2019s disease: the role of tryptophan metabolism Cell Commun Signal 23 1 424 https:\/\/doi.org\/10.1186\/s12964-025-02393-8","journal-title":"Cell Commun Signal"},{"issue":"Suppl 6","key":"5917_CR245","doi-asserted-by":"publisher","first-page":"S63","DOI":"10.1002\/mds.10565","volume":"18","author":"M Emre","year":"2003","unstructured":"Emre M (2003) What causes mental dysfunction in Parkinson\u2019s disease? Mov Disord 18(Suppl 6):S63-71. https:\/\/doi.org\/10.1002\/mds.10565","journal-title":"Mov Disord"},{"issue":"5","key":"5917_CR246","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.tins.2007.03.006","volume":"30","author":"A Bjorklund","year":"2007","unstructured":"A Bjorklund SB Dunnett 2007 Dopamine neuron systems in the brain: an update Trends Neurosci 30 5 194 202 https:\/\/doi.org\/10.1016\/j.tins.2007.03.006","journal-title":"Trends Neurosci"},{"issue":"1","key":"5917_CR247","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/0006-8993(90)90733-r","volume":"510","author":"GM Halliday","year":"1990","unstructured":"GM Halliday PC Blumbergs RG Cotton WW Blessing LB Geffen 1990 Loss of brainstem serotonin- and substance P-containing neurons in Parkinson\u2019s disease Brain Res 510 1 104 107 https:\/\/doi.org\/10.1016\/0006-8993(90)90733-r","journal-title":"Brain Res"},{"issue":"6","key":"5917_CR248","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10061299","volume":"10","author":"J Ojeda","year":"2021","unstructured":"Ojeda J, Avila A, Vidal PM (2021) Gut microbiota interaction with the Central Nervous System throughout life. J Clin Med 10(6):1299. https:\/\/doi.org\/10.3390\/jcm10061299","journal-title":"J Clin Med"},{"issue":"11","key":"5917_CR249","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1097\/CM9.0000000000002212","volume":"136","author":"L Liu","year":"2023","unstructured":"L Liu H Wang X Chen P Xie 2023 Gut microbiota: a new insight into neurological diseases Chin Med J (Engl) 136 11 1261 1277 https:\/\/doi.org\/10.1097\/CM9.0000000000002212","journal-title":"Chin Med J (Engl)"},{"key":"5917_CR250","doi-asserted-by":"publisher","DOI":"10.1038\/nmicrobiol.2017.57","volume":"2","author":"PW O\u2019Toole","year":"2017","unstructured":"O\u2019Toole PW, Marchesi JR, Hill C (2017) Next-generation probiotics: the spectrum from probiotics to live biotherapeutics. Nat Microbiol 2:17057. https:\/\/doi.org\/10.1038\/nmicrobiol.2017.57","journal-title":"Nat Microbiol"},{"issue":"12","key":"5917_CR251","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s11910-017-0802-6","volume":"17","author":"EMM Quigley","year":"2017","unstructured":"EMM Quigley 2017 Microbiota-brain-gut axis and neurodegenerative diseases Curr Neurol Neurosci Rep 17 12 94 https:\/\/doi.org\/10.1007\/s11910-017-0802-6","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"2","key":"5917_CR252","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1194\/jlr.R500013-JLR200","volume":"47","author":"JM Ridlon","year":"2006","unstructured":"JM Ridlon DJ Kang PB Hylemon 2006 Bile salt biotransformations by human intestinal bacteria J Lipid Res 47 2 241 259 https:\/\/doi.org\/10.1194\/jlr.R500013-JLR200","journal-title":"J Lipid Res"},{"issue":"1","key":"5917_CR253","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","volume":"24","author":"A Wahlstrom","year":"2016","unstructured":"A Wahlstrom SI Sayin HU Marschall F Backhed 2016 Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism Cell Metab 24 1 41 50 https:\/\/doi.org\/10.1016\/j.cmet.2016.05.005","journal-title":"Cell Metab"},{"issue":"7813","key":"5917_CR254","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41586-020-2396-4","volume":"582","author":"M Funabashi","year":"2020","unstructured":"Funabashi M, Grove TL, Wang M, Varma Y, McFadden ME, Brown LC, Guo C, Higginbottom S et al (2020) A metabolic pathway for bile acid dehydroxylation by the gut microbiome. Nature 582 (7813):566-570. https:\/\/doi.org\/10.1038\/s41586-020-2396-4","journal-title":"Nature"},{"issue":"3","key":"5917_CR255","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1007\/s10620-020-06715-3","volume":"66","author":"S Fiorucci","year":"2021","unstructured":"S Fiorucci A Carino M Baldoni L Santucci E Costanzi L Graziosi E Distrutti M Biagioli 2021 Bile acid signaling in inflammatory bowel diseases Dig Dis Sci 66 3 674 693 https:\/\/doi.org\/10.1007\/s10620-020-06715-3","journal-title":"Dig Dis Sci"},{"issue":"5","key":"5917_CR256","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1053\/j.gastro.2011.07.046","volume":"141","author":"KB Islam","year":"2011","unstructured":"KB Islam S Fukiya M Hagio N Fujii S Ishizuka T Ooka Y Ogura T Hayashi A Yokota 2011 Bile acid is a host factor that regulates the composition of the cecal microbiota in rats Gastroenterology 141 5 1773 1781 https:\/\/doi.org\/10.1053\/j.gastro.2011.07.046","journal-title":"Gastroenterology"},{"issue":"2","key":"5917_CR257","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","volume":"17","author":"SI Sayin","year":"2013","unstructured":"Sayin SI, Wahlstrom A, Felin J, Jantti S, Marschall HU, Bamberg K, Angelin B, Hyotylainen T et al (2013) Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab 17 (2):225-235. https:\/\/doi.org\/10.1016\/j.cmet.2013.01.003","journal-title":"Cell Metab"},{"issue":"4","key":"5917_CR258","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.chom.2020.01.021","volume":"27","author":"SR Sinha","year":"2020","unstructured":"Sinha SR, Haileselassie Y, Nguyen LP, Tropini C, Wang M, Becker LS, Sim D, Jarr K, et al. (2020) Dysbiosis-induced secondary bile acid deficiency promotes intestinal inflammation. Cell Host Microbe 27(4):659\u2013670. https:\/\/doi.org\/10.1016\/j.chom.2020.01.021","journal-title":"Cell Host Microbe"},{"issue":"2","key":"5917_CR259","doi-asserted-by":"publisher","first-page":"67","DOI":"10.14802\/jmd.18067","volume":"12","author":"HL Chiang","year":"2019","unstructured":"HL Chiang CH Lin 2019 Altered gut microbiome and intestinal pathology in Parkinson\u2019s disease J Mov Disord 12 2 67 83 https:\/\/doi.org\/10.14802\/jmd.18067","journal-title":"J Mov Disord"},{"issue":"2","key":"5917_CR260","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3727\/105221618X15156018385515","volume":"18","author":"JYL Chiang","year":"2018","unstructured":"JYL Chiang JM Ferrell 2018 Bile acid metabolism in liver pathobiology Gene Expr 18 2 71 87 https:\/\/doi.org\/10.3727\/105221618X15156018385515","journal-title":"Gene Expr"},{"issue":"8","key":"5917_CR261","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.bbadis.2011.04.005","volume":"1812","author":"RM Gadaleta","year":"2011","unstructured":"Gadaleta RM, Oldenburg B, Willemsen EC, Spit M, Murzilli S, Salvatore L, Klomp LW, Siersema PD et al (2011) Activation of bile salt nuclear receptor FXR is repressed by pro-inflammatory cytokines activating NF-kappaB signaling in the intestine. Biochim Biophys Acta 1812 (8):851-858. https:\/\/doi.org\/10.1016\/j.bbadis.2011.04.005","journal-title":"Biochim Biophys Acta"},{"key":"5917_CR262","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1146\/annurev.biochem.72.121801.161712","volume":"72","author":"DW Russell","year":"2003","unstructured":"DW Russell 2003 The enzymes, regulation, and genetics of bile acid synthesis Annu Rev Biochem 72 137 174 https:\/\/doi.org\/10.1146\/annurev.biochem.72.121801.161712","journal-title":"Annu Rev Biochem"},{"issue":"4","key":"5917_CR263","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1136\/gutjnl-2012-302578","volume":"62","author":"H Duboc","year":"2013","unstructured":"Duboc H, Rajca S, Rainteau D, Benarous D, Maubert MA, Quervain E, Thomas G, Barbu V et al (2013) Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases. Gut 62 (4):531-539. https:\/\/doi.org\/10.1136\/gutjnl-2012-302578","journal-title":"Gut"},{"issue":"17","key":"5917_CR264","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21175982","volume":"21","author":"SM Grant","year":"2020","unstructured":"SM Grant S DeMorrow 2020 Bile acid signaling in neurodegenerative and neurological disorders Int J Mol Sci 21 17 5982https:\/\/doi.org\/10.3390\/ijms21175982","journal-title":"Int J Mol Sci"},{"issue":"2","key":"5917_CR265","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s12035-012-8295-4","volume":"46","author":"M Castro-Caldas","year":"2012","unstructured":"M Castro-Caldas AN Carvalho E Rodrigues CJ Henderson CR Wolf CM Rodrigues MJ Gama 2012 Tauroursodeoxycholic acid prevents MPTP-induced dopaminergic cell death in a mouse model of Parkinson\u2019s disease Mol Neurobiol 46 2 475 486 https:\/\/doi.org\/10.1007\/s12035-012-8295-4","journal-title":"Mol Neurobiol"},{"issue":"1","key":"5917_CR266","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-022-00307-z","volume":"11","author":"K Khalaf","year":"2022","unstructured":"K Khalaf P Tornese A Cocco A Albanese 2022 Tauroursodeoxycholic acid: a potential therapeutic tool in neurodegenerative diseases Transl Neurodegener 11 1 33https:\/\/doi.org\/10.1186\/s40035-022-00307-z","journal-title":"Transl Neurodegener"},{"issue":"8","key":"5917_CR267","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.2174\/1570159X21666230907152207","volume":"22","author":"J Li","year":"2024","unstructured":"J Li Z Huang Y Jin L Liang Y Li K Xu W Zhou X Li 2024 Neuroprotective effect of tauroursodeoxycholic acid (TUDCA) on in vitro and in vivo models of retinal disorders: a systematic review Curr Neuropharmacol 22 8 1374 1390 https:\/\/doi.org\/10.2174\/1570159X21666230907152207","journal-title":"Curr Neuropharmacol"},{"issue":"21","key":"5917_CR268","doi-asserted-by":"publisher","first-page":"3942","DOI":"10.1016\/j.jmb.2018.08.019","volume":"430","author":"SM Bell","year":"2018","unstructured":"Bell SM, Barnes K, Clemmens H, Al-Rafiah AR, Al-Ofi EA, Leech V, Bandmann O, Shaw PJ et al (2018) Ursodeoxycholic Acid Improves Mitochondrial Function and Redistributes Drp1 in Fibroblasts from Patients with Either Sporadic or Familial Alzheimer's Disease. J Mol Biol 430 (21):3942-3953. https:\/\/doi.org\/10.1016\/j.jmb.2018.08.019","journal-title":"J Mol Biol"},{"issue":"3","key":"5917_CR269","doi-asserted-by":"publisher","first-page":"211","DOI":"10.2174\/187153007781662521","volume":"7","author":"K Vafeiadou","year":"2007","unstructured":"K Vafeiadou D Vauzour JP Spencer 2007 Neuroinflammation and its modulation by flavonoids Endocr Metab Immune Disord Drug Targets 7 3 211 224 https:\/\/doi.org\/10.2174\/187153007781662521","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"7","key":"5917_CR270","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10071501","volume":"10","author":"S Wu","year":"2022","unstructured":"S Wu C Garcia-Rama L Romero-Ramirez J Munter de EC Wolters BW Kramer J Mey 2022 Tauroursodeoxycholic acid reduces neuroinflammation but does not support long term functional recovery of rats with spinal cord injury Biomedicines 10 7 1501https:\/\/doi.org\/10.3390\/biomedicines10071501","journal-title":"Biomedicines"},{"issue":"Pt 10","key":"5917_CR271","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1093\/brain\/awt224","volume":"136","author":"H Mortiboys","year":"2013","unstructured":"H Mortiboys J Aasly O Bandmann 2013 Ursocholanic acid rescues mitochondrial function in common forms of familial Parkinson\u2019s disease Brain 136 Pt 10 3038 3050 https:\/\/doi.org\/10.1093\/brain\/awt224","journal-title":"Brain"},{"key":"5917_CR272","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.00524","volume":"11","author":"R Rajan","year":"2020","unstructured":"Rajan R, Divya KP, Kandadai RM, Yadav R, Satagopam VP, Madhusoodanan UK, Agarwal P, Kumar N, et al. (2020) Genetic architecture of Parkinson\u2019s disease in the Indian population: harnessing genetic diversity to address critical gaps in Parkinson\u2019s disease research. Front Neurol 11:524. https:\/\/doi.org\/10.3389\/fneur.2020.00524","journal-title":"Front Neurol"},{"key":"5917_CR273","doi-asserted-by":"publisher","unstructured":"Rai SN, Singh S, Singh SK (2024) Neurodegenerative diseases: translational models, mechanisms, and therapeutics. Neurodegener Dis: Transl Model, Mech, and Ther:1\u2013236. https:\/\/doi.org\/10.1201\/9781032620442\/NEURODEGENERATIVE-DISEASES-SACHCHIDA-NAND-RAI-SANDEEP-SINGH-SANTOSH-KUMAR-SINGH\/RIGHTS-AND-PERMISSIONS","DOI":"10.1201\/9781032620442\/NEURODEGENERATIVE-DISEASES-SACHCHIDA-NAND-RAI-SANDEEP-SINGH-SANTOSH-KUMAR-SINGH\/RIGHTS-AND-PERMISSIONS"},{"issue":"5","key":"5917_CR274","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1021\/acschemneuro.8b00733","volume":"10","author":"D Bhattacharyya","year":"2019","unstructured":"Bhattacharyya D, Mohite GM, Krishnamoorthy J, Gayen N, Mehra S, Navalkar A, Kotler SA, Ratha BN et al (2019) Lipopolysaccharide from Gut Microbiota Modulates alpha-Synuclein Aggregation and Alters Its Biological Function. ACS Chem Neurosci 10 (5):2229-2236. https:\/\/doi.org\/10.1021\/acschemneuro.8b00733","journal-title":"ACS Chem Neurosci"},{"issue":"7","key":"5917_CR275","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1002\/mds.29432","volume":"38","author":"GC Brown","year":"2023","unstructured":"GC Brown M Camacho CH Williams-Gray 2023 The endotoxin hypothesis of Parkinson\u2019s disease Mov Disord 38 7 1143 1155 https:\/\/doi.org\/10.1002\/mds.29432","journal-title":"Mov Disord"},{"issue":"1","key":"5917_CR276","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-021-00271-0","volume":"10","author":"AM Gorecki","year":"2021","unstructured":"Gorecki AM, Anyaegbu CC, Anderton RS (2021) TLR2 and TLR4 in Parkinson\u2019s disease pathogenesis: the environment takes a toll on the gut. Transl Neurodegener 10(1):47. https:\/\/doi.org\/10.1186\/s40035-021-00271-0","journal-title":"Transl Neurodegener"},{"issue":"12","key":"5917_CR277","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.1038\/s41591-024-03270-6","volume":"30","author":"G Pagano","year":"2024","unstructured":"Pagano G, Monnet A, Reyes A, Ribba B, Svoboda H, Kustermann T, Simuni T, Postuma RB, et al. (2024) Sustained effect of prasinezumab on Parkinson\u2019s disease motor progression in the open-label extension of the PASADENA trial. Nat Med 30(12):3669\u20133675. https:\/\/doi.org\/10.1038\/s41591-024-03270-6","journal-title":"Nat Med"},{"issue":"5","key":"5917_CR278","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209137","volume":"102","author":"RM Hutchison","year":"2024","unstructured":"Hutchison RM, Fraser K, Yang M, Fox T, Hirschhorn E, Njingti E, Scott D, Bedell BJ et al (2024) Cinpanemab in Early Parkinson Disease: Evaluation of Biomarker Results From the Phase 2 SPARK Clinical Trial. Neurology 102 (5):e209137. https:\/\/doi.org\/10.1212\/WNL.0000000000209137","journal-title":"Neurology"},{"issue":"2","key":"5917_CR279","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/mds.27562","volume":"34","author":"A Heras-Garvin","year":"2019","unstructured":"Heras-Garvin A, Weckbecker D, Ryazanov S, Leonov A, Griesinger C, Giese A, Wenning GK, Stefanova N (2019) Anle138b modulates alpha-synuclein oligomerization and prevents motor decline and neurodegeneration in a mouse model of multiple system atrophy Mov Disord 34 2 255 263 https:\/\/doi.org\/10.1002\/mds.27562","journal-title":"Mov Disord"},{"issue":"10","key":"5917_CR280","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1002\/mds.29170","volume":"37","author":"JW Smit","year":"2022","unstructured":"Smit JW, Basile P, Prato MK, Detalle L, Mathy FX, Schmidt A, Lalla M, Germani M et al (2022) Phase 1\/1b Studies of UCB0599, an Oral Inhibitor of alpha-Synuclein Misfolding, Including a Randomized Study in Parkinson's Disease. Mov Disord 37 (10):2045-2056. https:\/\/doi.org\/10.1002\/mds.29170","journal-title":"Mov Disord"},{"issue":"7","key":"5917_CR281","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/S1474-4422(20)30136-8","volume":"19","author":"D Volc","year":"2020","unstructured":"Volc D, Poewe W, Kutzelnigg A, Luhrs P, Thun-Hohenstein C, Schneeberger A, Galabova G, Majbour N et al (2020) Safety and immunogenicity of the alpha-synuclein active immunotherapeutic PD01A in patients with Parkinson's disease: a randomised, single-blinded, phase 1 trial. Lancet Neurol 19 (7):591-600. https:\/\/doi.org\/10.1016\/S1474-4422(20)30136-8","journal-title":"Lancet Neurol"},{"key":"5917_CR282","doi-asserted-by":"publisher","DOI":"10.1016\/j.mib.2025.102599","volume":"85","author":"S Fernandez-Veledo","year":"2025","unstructured":"S Fernandez-Veledo C Grau-Bove S Notararigo I Huber-Ruano 2025 The role of microbial succinate in the pathophysiology of inflammatory bowel disease: mechanisms and therapeutic potential Curr Opin Microbiol 85 102599https:\/\/doi.org\/10.1016\/j.mib.2025.102599","journal-title":"Curr Opin Microbiol"},{"key":"5917_CR283","doi-asserted-by":"publisher","unstructured":"Kumar A, Bagchi D (2021) Antioxidants and functional foods for neurodegenerative disorders: uses in prevention and therapy. Antioxid Funct Foods for Neurodegener Disord: Uses in Prev Ther:1\u2013473. https:\/\/doi.org\/10.1201\/9780429319310\/ANTIOXIDANTS-FUNCTIONAL-FOODS-NEURODEGENERATIVE-DISORDERS-ABHAI-KUMAR-DEBASIS-BAGCHI","DOI":"10.1201\/9780429319310\/ANTIOXIDANTS-FUNCTIONAL-FOODS-NEURODEGENERATIVE-DISORDERS-ABHAI-KUMAR-DEBASIS-BAGCHI"},{"key":"5917_CR284","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26010229","author":"T Meng","year":"2021","unstructured":"Meng T, Xiao D, Muhammed A, Deng J, Chen L, He J (2021) Anti-inflammatory action and mechanisms of Resveratrol. Molecules. https:\/\/doi.org\/10.3390\/molecules26010229","journal-title":"Molecules"},{"issue":"2","key":"5917_CR285","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.neurobiolaging.2006.10.009","volume":"29","author":"A Floel","year":"2008","unstructured":"A Floel G Garraux B Xu C Breitenstein S Knecht P Herscovitch LG Cohen 2008 Levodopa increases memory encoding and dopamine release in the striatum in the elderly Neurobiol Aging 29 2 267 279 https:\/\/doi.org\/10.1016\/j.neurobiolaging.2006.10.009","journal-title":"Neurobiol Aging"},{"issue":"1","key":"5917_CR286","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.brs.2016.10.005","volume":"10","author":"A Muralidharan","year":"2017","unstructured":"A Muralidharan J Zhang D Ghosh MD Johnson KB Baker JL Vitek 2017 Modulation of neuronal activity in the motor thalamus during GPi-DBS in the MPTP nonhuman primate model of Parkinson\u2019s disease Brain Stimul 10 1 126 138 https:\/\/doi.org\/10.1016\/j.brs.2016.10.005","journal-title":"Brain Stimul"},{"key":"5917_CR287","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.852003","volume":"13","author":"S Menon","year":"2022","unstructured":"S Menon S Armstrong A Hamzeh NP Visanji SP Sardi A Tandon 2022 Alpha-Synuclein targeting therapeutics for Parkinson\u2019s disease and related synucleinopathies Front Neurol 13 852003https:\/\/doi.org\/10.3389\/fneur.2022.852003","journal-title":"Front Neurol"},{"issue":"1","key":"5917_CR288","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-024-00404-1","volume":"13","author":"YY Ma","year":"2024","unstructured":"Ma YY, Li X, Yu JT, Wang YJ (2024) Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside. Transl Neurodegener 13(1):12. https:\/\/doi.org\/10.1186\/s40035-024-00404-1","journal-title":"Transl Neurodegener"},{"issue":"7","key":"5917_CR289","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1016\/j.clnu.2024.05.036","volume":"43","author":"AM Mincic","year":"2024","unstructured":"AM Mincic M Antal L Filip D Miere 2024 Modulation of gut microbiome in the treatment of neurodegenerative diseases: a systematic review Clin Nutr 43 7 1832 1849 https:\/\/doi.org\/10.1016\/j.clnu.2024.05.036","journal-title":"Clin Nutr"},{"issue":"2","key":"5917_CR290","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2019.12.078","volume":"30","author":"ME Goya","year":"2020","unstructured":"Goya ME, Xue F, Sampedro-Torres-Quevedo C, Arnaouteli S, Riquelme-Dominguez L, Romanowski A, Brydon J, Ball KL, et al. (2020) Probiotic Bacillus subtilis protects against alpha-Synuclein aggregation in C. elegans. Cell Rep 30(2):e367. https:\/\/doi.org\/10.1016\/j.celrep.2019.12.078","journal-title":"Cell Rep"},{"issue":"1","key":"5917_CR291","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-27086-x","volume":"13","author":"ME Caetano-Silva","year":"2023","unstructured":"ME Caetano-Silva L Rund NT Hutchinson JA Woods AJ Steelman RW Johnson 2023 Inhibition of inflammatory microglia by dietary fiber and short-chain fatty acids Sci Rep 13 1 2819https:\/\/doi.org\/10.1038\/s41598-022-27086-x","journal-title":"Sci Rep"},{"issue":"5","key":"5917_CR292","doi-asserted-by":"publisher","first-page":"e772","DOI":"10.1212\/WNL.0000000000010998","volume":"96","author":"AH Tan","year":"2021","unstructured":"Tan AH, Lim SY, Chong KK, MAA AM, Hor JW, Lim JL, Low SC, Chong CW et al (2021) Probiotics for Constipation in Parkinson Disease: A Randomized Placebo-Controlled Study. Neurology 96 (5):e772-e782. https:\/\/doi.org\/10.1212\/WNL.0000000000010998","journal-title":"Neurology"},{"key":"5917_CR293","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1104759","volume":"14","author":"HL DuPont","year":"2023","unstructured":"DuPont HL, Suescun J, Jiang ZD, Brown EL, Essigmann HT, Alexander AS, DuPont AW, Iqbal T et al (2023) Fecal microbiota transplantation in Parkinson's disease-A randomized repeat-dose, placebo-controlled clinical pilot study. Front Neurol 14:1104759. https:\/\/doi.org\/10.3389\/fneur.2023.1104759","journal-title":"Front Neurol"},{"key":"5917_CR294","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12081871","author":"E Zikou","year":"2024","unstructured":"E Zikou C Koliaki K Makrilakis 2024 The role of fecal microbiota transplantation (FMT) in the management of metabolic diseases in humans: a narrative review Biomedicines https:\/\/doi.org\/10.3390\/biomedicines12081871","journal-title":"Biomedicines"},{"key":"5917_CR295","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.ibneur.2023.09.003","volume":"15","author":"S Nomura","year":"2023","unstructured":"S Nomura H Katoh S Yanagisawa T Noguchi K Okada M Watanabe 2023 Administration of the GLP-1 receptor agonist exenatide in rats improves functional recovery after spinal cord injury by reducing endoplasmic reticulum stress IBRO Neurosci Rep 15 225 234 https:\/\/doi.org\/10.1016\/j.ibneur.2023.09.003","journal-title":"IBRO Neurosci Rep"},{"issue":"4","key":"5917_CR296","doi-asserted-by":"publisher","first-page":"657","DOI":"10.3233\/JPD-230363","volume":"14","author":"RK Wyse","year":"2024","unstructured":"Wyse RK, Isaacs T, Barker RA, Cookson MR, Dawson TM, Devos D, Dexter DT, Duffen J et al (2024) Twelve Years of Drug Prioritization to Help Accelerate Disease Modification Trials in Parkinson's Disease: The International Linked Clinical Trials Initiative. J Parkinsons Dis 14 (4):657-666. https:\/\/doi.org\/10.3233\/JPD-230363","journal-title":"J Parkinsons Dis"},{"issue":"11","key":"5917_CR297","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.bbagen.2008.02.005","volume":"1780","author":"SJ Chinta","year":"2008","unstructured":"SJ Chinta JK Andersen 2008 Redox imbalance in Parkinson\u2019s disease Biochim Biophys Acta 1780 11 1362 1367 https:\/\/doi.org\/10.1016\/j.bbagen.2008.02.005","journal-title":"Biochim Biophys Acta"},{"issue":"2_suppl","key":"5917_CR298","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1177\/0271678X231156500","volume":"43","author":"W Qu","year":"2023","unstructured":"W Qu KM Ralto T Qin Y Cheng W Zong X Luo M Perez-Pinzon SM Parikh C Ayata 2023 NAD(+) precursor nutritional supplements sensitize the brain to future ischemic events J Cereb Blood Flow Metab 43 2_suppl 37 48 https:\/\/doi.org\/10.1177\/0271678X231156500","journal-title":"J Cereb Blood Flow Metab"},{"issue":"6","key":"5917_CR299","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1517\/13543784.14.6.729","volume":"14","author":"P Jenner","year":"2005","unstructured":"P Jenner 2005 Istradefylline, a novel adenosine A2A receptor antagonist, for the treatment of Parkinson\u2019s disease Expert Opin Investig Drugs 14 6 729 738 https:\/\/doi.org\/10.1517\/13543784.14.6.729","journal-title":"Expert Opin Investig Drugs"},{"issue":"s1","key":"5917_CR300","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.3233\/JPD-179002","volume":"7","author":"A Bjorklund","year":"2017","unstructured":"A Bjorklund O Lindvall 2017 Replacing dopamine neurons in Parkinson\u2019s disease: how did it happen? J Parkinsons Dis 7 s1 S21 S31 https:\/\/doi.org\/10.3233\/JPD-179002","journal-title":"J Parkinsons Dis"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05917-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-05917-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05917-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T07:15:14Z","timestamp":1779174914000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-05917-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":300,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5917"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-05917-6","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"8 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"639"}}